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Introduction 
Need for prevention? 
One of the major achievements of medicine in this century is its contribution to the 
increase in life expectancy at birth. Nowadays. this is reflected in the growing Humber 
of older adults. Unfortunately, part of this group will spend old age in poor health. 
The consequences for older individuals, their care givers and the society at large. 
raises the question whether the occurrence of disease in later life can be postponed or 
even prevented. 
Goals of prevention 
Prevention of disease can have different aims. Firstly. it call be directed at preventing 
premature death. Secondly. prevention can aim at reducing morbidity. If our 
preventive programmes are successful, morbidity may be compressed to a short 
period at the end of life. However, if preventive programmes also increase life 
expectancy, expansion of morbidity may occur. Thirdly, preventive efforts can try to 
improve functional status and maintain independence of older adults. 
Prevention in the elderly 
Ideally, prevention of morbidity and mortality should start early in life, before a life 
long exposure to risk factors has caused irreversible damage. Nevertheless, many 
preventive measures are beneficial at old age. It should be recognised that in later life 
a similar relative reduction in the occurrence of, for example cardiovascular, disease 
often has a more substantial impact on the absolute number of cases of disease that 
can be prevented, since the absolute risk of most diseases is higher in older compared 
to younger subjects. Towards the end of life, the first goal of prevention, the reduction 
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of premature death, is progressively replaced by the other two goals of prevention; the 
prevention or postponement of morbidity and the improvement of quality of life. 
Structured preventive care offered to older adults? 
Different health care systems offer diverging preventive care for older adults. In the 
United Kingdom, the health status of patients of 75 years is assessed yeady during a 
screening examination by their general practitioner. In the Netherlands, where no such 
structured form of preventive care is offered to the elderly, case finding. i.e. a targeted 
screen for risk factors of disease in those visiting the general practitioner, is advocated 
by many. A lack of research data contributes to these divergent pollcies. 
Objective of this thesis 
Tilis thesis aims at investigating the screening yield and feasibility of two distinct 
types of preventive care that can be offered to older adults by their general 
practitioner; screening on cardiovascular risk factors and screening on hearing loss. 
Screening on cardiovascular risk factors represents screening efforts directed at 
reducing morbidity and mortality, while screening on hearing loss aims at improving 
functional status. 
In chapter 1 we discuss the promises and drawbacks of these two types of screening 
by applying the criteria of Wilson. 
Chapter 2 to 5 describe several studies we conducted to establish the value of 
screening older adults for cardiovascular risk indicators. The cardiovascular screening 
examination, which was offered to all adults aged 60 and over (n=1002) enlisted in 
one group practice, is described in chapter 2. The number of risk factors observed 
during the screening examination but not recorded in the patient file at that time is 
taken as the screening yield. We offered a repeated screening examination to the same 
group of patients five years later to explore the desirability of repeated screening. 
(Chapter 3) The screening yield of the repeated screening examination is assessed. 
Next we focus on one aspect of a cardiovascular screening examination that is often 
advocated in the Netherlands, although empirical evidence on its value is virtually 
lacking; the review of cardiovascular medication use by older adults. A cardiovascular 
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screening examination may include electrocardiography. notably since computerised 
interpretation programs have become available which facilitate the use of EeGs by 
general practitioners. Chapter 5 describes the screening yield of an 
electrocardiographic screening performed among 489 older adults. Furthermore, the 
consequences of the detection of previously unknown electrocardiographic 
abnormalities are reported. 
Screening on hearing disorders is discllssed in chapter 6. The effects of screening by 
pure tone audiometry on the issuing of hearing aids is determined after a single and 
repeated audiometric screen after five years. 
Finally. chapter 7 critically discusses the issues addressed in this thesis. As a guideline 
for the discussion, the controversies of screening which were identified by Schaapveld 
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HEALTH CHECKS IN TIlE EI.DERl-Y; PROMISES AND UNRESOLVEDARh'AS 
Introduction 
During the last decades, western countries have witnessed a growth of their older 
population. Nowadays, people live longer than ever before. (I) In the Netherlands, life 
expectancy at bh1h in 1994 was 2.1 year higher for men and 1.1 year higher for 
women compared to 1980 and is predicted to have risen by 2.5 years for men and by 
1.0 year for women by 2015. (2) However, not all older adults spend those extra years 
in good health. Of their 74.3 years, which is the life expectancy at birth in the 
Netherlands, men will spend on average only 60.1 years in good health. (3) 
In view of this seemingly inevitable burden of disease, efforts to postpone disease and 
preserve good health in the elderly are becoming more important. Although major 
diseases of later life are associated with the presence of risk factors in earlier life, 
preventive efforts can still be flUitful at an older age. (4, 5) Prevention at older age 
aims at increasing the ability of older adults to live independently by offering 
interventions to reduce or postpone mortality and the occurrence of disease or to 
improve functional status. For example, the treatment of hypertension is directed at 
the latter two endpoints whereas the prescription of a hearing aid is expected to reduce 
disability and handicap. Generally, the older a person becomes, the more the aim of 
prevention shifts toward improvement of functional status. (6) 
The usefulness of offering preventive services to older persons in primary care has 
been vigorously debated. In the UK, the Royal College of General Practitioners 
advocates more emphasis on preventive care for the elderly. This is in line with the 
obligation general practitioners in the UK have to perform health checks as a part of 
their contract with the NHS, which in the early nineties considered prevention a 
powerful tool to reduce health care costs. However, in clinical practice the effort 
which practices invest in performing the contractual health checks varies greatly. (7-
9) Apparently, most general practitioners are not fully convinced of the benefits of 
preventive care jn the elderly and consider it superfluous. 
The present ru1icle addresses this issue by discussing the promises and unresolved 
ru'eas of preventive care for the elderly in general practice. As a guideline for the 
desirability of screening initiatives, we use Wilson's criteria. (10) (Table \) Although 
these criteria were published in 1965, they remain relevant today and are cited in 
somewhat revised form in many national guidelines involving screening. (11-14) 
Although the possibilities for preventive care in older adults are I)umerous, this article 
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will be restricted to discuss the prevention of cardiovascular disease, which is the 
main cause of morbidity and mortality in the elderly, and the prevention of the 
consequences of hearing loss, which is a major cause of disability and handicap at 
older age, with reference to these criteria. 
Table 1 Wilson's criteria for screening. 




there must be a recognised latent or early symptomatic slage 
the natural history must be understood 
a suitable test or examination must be available 
the test must be acceptable to the population screened 
screening must be a continuous process 
facilities must exist for assessment and treatment 
there must be an accepted form of effective treatment 
there should be an agreed policy on whom to treat 
the cost must be economically balanced in relation to possible expenditure 011 medical 
care as a whole 
Prevention of cardiovascular disease 
The disease should be all important problem. 
This condition is clearly met by cardiovascular disease. as it is the most conmlon 
cause of mortality and is one of the leading causes of limitations of activities in later 
life. Although in developed countries age-adjusted cardiovascular disease mortality 
rates tends to decrease since the seventies, it remains the most important cause of 
death. For example, in the Netherlands cardiovascular disease is responsible for 39% 
of all deaths, while neoplasms cause 27% of all deaths. (15) 
One of the reasons for the decline in cardiovascular mortality is the improved case 
fatality after myocardial infarction. However, survivors of myocardial infarction are at 
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high risk for other cardiovascular morbidity, particularly heart failure. A decrease in 
cardiovascular mortality is not matched by a equal decrease in morbidity, as is 
illustrated by the increase in hospital admissions because of heart failure in this age 
group. (16) 
There must be a recognised latent or early symptomatic stage 
The existence of subclinical cardiovascular disease can be demonstrated in a number 
of ways. Examples include the presence of certain ECG abnormalities, 
echographically determined intima media thickness or stenosis of the carotid artery, 
and a"low ankle/arm index. These objective measures of subclinical disease have been 
shown to independently predict mortality in older adults. (17) 
Nevertheless, although cardiovascular disease can be identified before its clinical 
stage, the strategy of preventive cardiology is directed at detecting those with 
cardiovascular risk factors. The fact that many of these risk factors can be modified 
explains their importance for clinical practice. Risk factors discussed in this thesis 
include hypertension, hyperchoiesterolaemia and diabetes mellitus. In addition, 
however, inappropriate use of cardiovascular medication is considered a risk factor 
since it significantly influences the risk of cardiovascular disease. (I8) 
Risk factors do not, by definition, predict cardiovascular disease in older adults in the 
same way as in younger adults. Generally, the association between the risk factor and 
cardiovascular disease becomes somewhat weaker as one ages, probably because of 
selective survival. Because of the high absolute risk for cardiovascular disease in 
older adults, however, even a weaker association is clinically significant. 
The natural histot)' must be understood 
The natural history of cardiovascular disease has been studied extensively and the 
prognosis of its different forms is rather poor. The first presentation of cardiovascular 
disease is fatal in onc third of all cases, The prognosis after myocardial infarction is 
variable and unfavourable when pre-existing cardiovascular conditions are present. 
(19) Heart failure is highly lethal, as approximately one third of patients dies within 
two years. (20) Peripheral arterial disease is progressive, leading not only to 
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amputation and arterial reconstmction in 8% of those with claudication over a five 
year period, but has also been associated with an increased risk for other 
cardiovascular events. (21) Stroke is fatal in 30% and only 72% survive the following 
four years. (22, 23) 
A suitable test or examination is available 
Tests that can be used in general practice for cardiovascular risk assessment include 
history taking, measurement of blood pressure, semm cholesterol- and glucose 
concentration, electrocardiography and measurement of the ankle/arm index. In 
contrast to the other tests, the latter two tests are not widely used by general 
practitioners in the Netherlands. 
The test must be acceptable to the populatio1l screened 
Because many cardiovascular screenings tests arc also part of the normal care of 
general practitioners, patients are familiar with them. Preventive studies including 
such tests generally reach response rates of 80% among middle aged participants. The 
response rates among older adults vary. In two comprehensive screening programmes 
of those above 75 years in the UK, response rates were 64% and 82%. (9) 
Screeni1lg mllst be a continllous process 
Since general practice is characterised by continuity of care, screening in general 
practice should be able to meet tltis criterion. For example, general practitioners iii the 
UK are contractually obliged to perform health checks at predefined intervals of 
adults above 75 years of age. (7) Likewise, the opportunistic screening advocated in 
the Netherlands is firmly based in guidelines of the Dutch College of General 
Practitioners, which mention screening intervals. (24) Nevertheless, there is a 
significant variation between general practitioners in preventive activities. 
10 
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Facilities must exist for assessmellf and treahnellt 
A potential advantage of screening in general practice is the close link bctween 
assessment and treatmcnt. However, the feasibility of screenings programmes 
performed by general practitioners is debated. The workload associated with 
screening and, at least equally imp0I1antly, the follow-up should not be 
underestimated. Additional investments jn general practice to facilitate preventive 
care may be needed. 
It should be noted, however, that preventive care is only one of the new challenges 
facing general practice today. For example, the ageing of the population itself will 
inevitably lead to a higher demand for primary care. Thus, improvement of the 
organisation of primary care seems mandatory to meet future requirements. 
There mllst be all accepted/onn of effective treatment 
The efficacy of dmg treatment of cardiovascular risk factors in older adults has been 
investigated in many randomised controlled trials. (5, 25-36) Table 2 summarises the 
major results of these trials. It is evident that cardiovascular morbidity and mortality 
can be postponed in older people. For example, a meta analysis of trials on the 
treatment of isolated systolic hypertension showed that during approximately five 
years of treatment cardiovascular morbidity and 1ll0I1ality was reduced by 34 percent. 
In absolute terms, this implied that in one of every 19 patients treated by 
antihypertensive drugs for five years a cardiovascular event would be prevented. (5) 
Another example deals with the treatment of hypercholesterolemia in adults aged 55-
65, without a history of myocardial infarction. In these patients, treatment over a 4.9 
year period with pravastatine reduced the occurrence of non fatal myocardial 
infarctions and deaths from cardiovascular disease by 27 percent. However, because 
the absolute risk of cardiovascular disease was low in this group, the relative 
reduction translated into a less impressive absolute risk reduction; in only one out of 
forty patients a cardiovascular event would be prevented during the 4.9 years of 
treatment. (25) 
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Table 2. Efficacy of drug interventions on cardiovascular risk factors in older adults. 
RRR= Relative Risk Reduction of the treated versus the placebo group in percentages during the follow up time of the triaL 
ARR= Absolute Risk Reduction of the treated versus the placebo group in percentages during the follow up time of the trial. 
NNT= Number of patients which must be treated for five years to prevent a primary endpoint in one of them. 
Risk factor Intervention Trial 
" 
Mota Primary Endpoint FoUow Age group RRR ARR NNT 
an:l.lysis up time (%) (%) (S YC3rs) 
hypenension. including isolated ;mti.hypenensive drugs Mulrow et al (5) cardiov:lScui.:lt mOrbidity and mortality - 5 yean; 6().80ff 29 5.1 20 
systolic hypertension 
isolated systolic hypertension only anti-hypertensive drugs Mulrow et a! (5) cardiovascular morbidity and mortality - 5 ye:ltS 60-80" 34 5.3 19 
hypercholesterolaemia sutins WQSCO?S (24) non fatal mi ;md deaths from CYD 4.9 years 55-65 27 2.5 40 
diabetes mellitus strict glycaemic control UKPDS 33 (25) myocardial infarction 10 years 25-65 years 13-22 0.21·0.38 476-263 
stroke -2.0-0.6 -0.20-0.06 n.a.-J666 
I 
myocardial infarction 6 blocker BHAT(26) all c.:tuse mortality 25 mnth 60-69 years 36 5.0 S I 
Norwegian Study 33 mnth 20-75 years 39 6.9 S 
(27) 
ospirin AntiplateJet V:lScular events 27 ?S 21 3.6 13 
Trialists (28) 
sutins CARE (30) major coronary events 5 year:; 60-75 years 27 7.0 14 
myocardia! infarction 
"'" 
sutins 4S (29) major coronary events 5.4 years 60-70 years 29 7.3 15 
hypercholeserolaemia 
- - -
myocardial infarction ""d left ACE inhibitors AffiE(31) toW moruJity 15months 65 years" 27 6,0 4 
ventricular dysfunction 
SAVE (32) 42months >64y~ 25 8.2 8 
TRACE (33) 24-50mn '2::65years 17 7.2 6-12 
atrial. fibrillation aspirin AFI(34) Stroke 1 year 70 years" 21 1.8 11 
cournarine deriv.::ues AFI (35) Stroke ly= 67%<:65yrs 68 3.1 6 
" . Most patients between 60-80 years. #: Absolute risk reduction in %. $ : Age of partiCipants not mentioned. The relative risk reduction in the group <65 however. was in 
the same range as in the group ::::65 years. A : Mean age. 
Table 3. Efficacy of life style interventions on cardiovascular risk factors in older adults. 
Risk fllctor Intervention Metllllnalysi.~ Primary Endpoint Age group Effect 
Smoking advice from physician Sigaly er al (36) abstinence from smoking '2:: 6 months adults (few 2:: 60 years) Odds of quitting: 1.73 (1.47-2.02) 
Hypertension dietary salt reduction Midgley et at (37) reduction in diastolic and systolic blood 45-73 years SBP: 6.3 (4.11_8.44) mm Hgper 100 mmolll change'" 
pressure DBP: 2.2 (0.58-3.87) mm Hg perlOO mmol/l change· 
Elevated serum step 1 diet adviced by dietitians Ramsay et at (38) reduction in total serum cholesterol lIdults. predominantly men. average reduction of2% 
cholesterol or occupational physicians concentration few "2: 60 years 
* : The dietary intervention effect averaged a reduction of95 mmoVd in daily sodium excretion for hypertensive subjects. 
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Only a few studies determined the effect of life style modifications on the risk of 
ardiovascular disease in older people with prevalent risk factors. (37-39) The majority 
of these studies were performed in the middle-aged (Table 3). First it should be 
emphasised that effects in older adults might differ from the results obtained in the 
middle aged. For example, in trials with dietary salt reduction, a greater reduction in 
blood pressure was observed in older compared to younger hypertensives. 
Nevertheless, it seems plausible that in accordance with the observations in drug 
trials, most beneficial effects of life style interventions demonstrated in middle aged 
people can also be expected to occur in older people. although the magnitude of these 
effects is not precisely known. 
There should be all agreed policy all whom to treat 
European and national guidelines and consensus reports agree on treatment of 
hypertension and isolated systolic hypertension for the prevention of coronary heart 
disease and stroke in subjects up to 80 years. (24, 40) The desirability of the use of 
lipid lowering drugs by older adults, however, is debated. (41) Recently, it was 
recommended in the Netherlands to restrict the prescription of lipid lowering dmgs to 
patients with evidence of coronary heart disease or with an IO-year absolute risk of 
coronary heart disease exceeding 25%. Furthermore. the latter group should not be 
older than 70 to be candidates for lipid lowering drugs. (42) 
The beneficial effects of coumarines or a':>pirin in patients with atrial fibrillation has 
been established. but a guideline of the Dutch College of General Practitioners on this 
subject is still lacking. (43, 44) Therapy to prevent the recurrence of myocardial 
infarction, for example by aspirin or lipid lowering drugs, is well recognised as useful 
in clinical practice. (40) 
The cost must be economically balanced ill relation to possible e.\jJellditure all 
medical care as a whole 
Two important clinical trials assessing the efficacy of cardiovascular health checks in 
middle aged adults, the British Family Heart study and the OXCHECK trial, 
presented a cost effectiveness analyses. (45-47) The programme cost per life year 
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gaincd was strongly depended on the assumed duration of the risk reduction. The 
costs for an individual aged 50 ranged from £ 15 300 assuming an one year effect in 
the British Family Heart study to £ 900 assuming a 20 year effect after intervention in 
the OXCHECK study. \Vhen the costs of these interventions were compared with 
other interventions in the field of preventive cardiology, it was concluded that the 
effect of the chcaper OXCHECK study and the more expensive British Family Heart 
study should last at least 5 years and 10 years, respectively, to justify the costs. 
Unfortunately, there is only limited data on the duration of the effect of such 
interventions. It should be noted, however, that the beneficial effects of the 
OXCHECK study were still present after three years of follow-up. 
15 
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PreYention of the consequences of hearing loss 
l'lte disease should be all important problem 
Hearing disorders are prevalent among older people. Hearing impairment takes the 
second place in men and the third place in women on the list of most frequent chronic 
conditions of older people in the US. (48) 
Hearing impairment is associated with social and emotional isolation and may even 
lead to depression and cognitive impairment. (49-51) 
There mllst be a recognised latent or early symptomatic stage 
By far the most frequent form of hearing disorder among older people is presbyacusis. 
Presbyacusis can be recognised on screenings tests or audiometric testing, even when 
patients are not aware of their hearing problems. (52) \Vhen patients tlrst become 
aware of their hearing loss, they may adapt themselves over time to their lower 
hearing ability. It is only when patients or their surroundings do not accept the lower 
quality of life associated with hearing impairment, that hearing loss becomes 
clinically apparent to the treating physician. 
The natural histOJ), must be understood 
The prevalence of hearing impainnent increases with age. (53) In an general practice 
based study, the prevalence increased from 23% in those aged 60-64 years to 76% in 
those over 80 years. (52) The rate of progression of hearing loss is studied in a few 
longitudinal investigations only. (54, 55) A recent study showed that after eight years, 
but not after three years, the deterioration of the hearing ability was statistically 
significant in a cohort of men aged 57-65 at the first audiometric screening. (56) The 
rate of deterioration was higher in older participants. 
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A suitable test or examination is available 
To detcct hearing loss, audioscopy or other pOIiable screening audiometers, whispered 
voice tests and self assessment questionnaires are available. An audioscope is an 
hand-held otoscope with a build-in audiometer and capable of delivering a 20, 25 or 
40 dB tone at frequencies of 500, 1000, 2000 and 4000 Hz. 
The whispered voice test is performed by whispering six words at a fixed distance and 
asking the patient to repeat those words. Of the self assessment questionnaires, the ten 
item Hearing Handicap Inventory for the Elderly - Screening Version (HHIE-S) is 
studied most extensively. 
Audi6scopy will invariably detect hearing loss more than 40 dB, but does not measure 
hearing ability in noisy environments. Questionnaires perform better in the detection 
of hearing handicaps, and may therefore better predict hearing aid llse after a positive 
screening result. However. they might miss sllccessful hearing aid candidates and may 
not be preferred by patients. (57, 58) The whispered voice test is easy to apply by 
general practitioners and is recommended in the UK to use as a screening test as part 
of the compulsory screening of older adults. (7) Unfortunately, its validity in a general 
practice setting has not been established. (59) 
Thus, all three screening tests have their own merits and a combination of tests may 
further improve the detection rate of hearing loss (57). 
The test mltst be acceptable to the population screened 
Pure tone audiography, audioscopy and the whispered voice test arc used as screening 
devices in general practice. Respons rates of 80% and 73% have been reported for 
studies in general practice. (60, 61) The acceptance of questionnaires when distributed 
by mail depends on the amount of effort invested in the follow-up of non-responders 
and may vary from 51% to 98%. (62) 
Screening mllst be a continllolls process 
As already discussed in the section on prevention of cardiovascular disease, although 
continuity of screening is theoretically guaranteed in the general practice setting, 
considerable differences between practices have been observed. 
17 
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Facilities IIIllst exist for (lssessmem and treatment 
This issue has already been discussed in the section on prevention of cardiovascular 
disease. In brief, there is doubt whether general practice can deal with the workload 
associated with screening activities and its follow up. 
There IIIl1st be all accepted form of effective treatment 
The effects of the prescription of hearing aids among hearing impaired elderly has 
been evaluated in one randomised controlled trial only. (63) This trial shmved an 
improvement among those who received a hearing aid compared to those on a waiting 
list for such a device, in social and emotional function (85%) and communication 
function (68%). Furthermore, among those with a hearing aid, the scores on the Short 
Portable Mental Status Questionnaire and the Geriatric Depression Scale were 30% 
and 26% higher, respectively. However, care must be taken when generalising these 
results of this trial to all hearing impaired subjects in the population at large since the 
trial participants consisted of motivated male patients with mild degrees of hearing 
loss. 
In addition, the effects of hearing aids were studied in before-after trials and case 
control studies, confirming the benefits of hearing aids on psychosocial functioning 
observed in the randomised trial. 
Although this evidence shows that hearing aids may be effective, studies show that in 
only 19% to 48% of hearing impaired subjects detected at audiometric screenings a 
hearing aid is prescribed. (60, 61) Patients with hearing loss can refrain from using 
hearing aids for various reasons including perceived low severity of the hearing 
problem, presumed passive acceptance of hearing loss, belief that the hearing problem 
is caused by others who do not speak clearly, poor image of hearing aids, costs, 
stigmatisation, lack of knowledge and misconceptions about hearing rehabilitation, 
professional attitudes and lack of social pressure from others to do something about 
the hearing problem. (64) In addition, age of the participant or degree of hearing loss 
differentiated potential users from non users in some, but not all shldies. (65) As 
mentioned above questionnaires, originally developed to measure hearing handicap, 
may better predict the uptake of hearing aids after screening. (66) 
18 
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There should be WI agreed policy on whom to treat 
There is no generally accepted guideline to assist in the decision whether or not to 
prescribe a hearing aid in subjects with hearing impairment. Hearing aids are 
reimbursed in the Netherlands if the average hearing loss in the best ear is above 35 
Hz. 
The cost must be economically balanced ill relation to possible e.\jJenditllre OIl 
medk;al care as a whole 
The cost of a screening programme on hearing loss has never been fully assessed. 
However, the major costs will foHow from the intervention; the issuing of hearing 
aids. These costs can be justified as long as the hearing impaired individual regularly 
wears his aid. However, non use of hearing aids frequently occurs, and this reduces 
the cost effectiveness of screening programmes on hearing loss. (67) 
To sum up, screening of older adults on cardiovascular risk factors and hearing loss 
meets most of \Vilson's criteria. Nonetheless, the evidence is not complete because 
there are areas which arc not covered by these criteria. Therefore, we discuss two 
additional criteria, which address the generalisabiJity of the evidence and the 
feasibility of screening older adults for cardiovascular disease and hearing disorders in 
general practice. 
111e empirical evidence must be applicable to older adults in a primary care setting 
Much of the evidence for the efficacy of screening has been obtained in adults up to 
70 years of age. The number of elderly above this age is large and increasing. 
The screening yield among older subjects may differ from middle aged subjects. On 
the one hand, the prevalence of risk factors is higher, which increases the screening 
yield. On the other hand, since the elderly visit their general practitioner often, risk 
factors are more likely to have been already identified, making screening redundant. 
Indeed, a large Norwegian study showed that almost all elderly patients with 
19 
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hypertension had already been identified as such by their general practitioner. In 
contrast, a cardiovascular health check in adults up to 70 years in New Zealand 
suggested 'that there were enough newly found risk factors to justify the effort'. 
These are the only earlier studies on the screening yield of cardiovascular health 
checks in older adults. Thus, there clearly is too little evidence on the issue. 
Knowledge of the screening yield can serve as a first step to assess the efficacy of 
screening, which is further determined by the number of interventions following a 
positive test results, the compliance with and the efficacy of that intervention. 
The screening programme must be feasible ill evel), day practice 
\Vilson's criteria provide a theoretical basis for making an informed decision about 
the desirability of screening programmes, but the feasibility of these programmes in 
every day practice remains to be proven. (68) This is illustrated by the variable way in 
which the compulsory screening for adults above 75 years is perfonned in the UK. 
(69) Although candidates are usually willing to participate, the organisation of 
preventive care by their general practitioner limits the uptake. For screening on 
cardiovascular disease or hearing disorders in older adults, there is no data to indicate 
what proportion of the eligible elderly will actually be screened, once these screenings 
programmes are introduced in general practice. 
Conclusion 
\Ve conclude that screening on cardiovascular risk factors and hearing loss by general 
practitioners seems promising as it meets most of \Vilson's criteria of screenings 
activities. Unfortunately, however, doubt remains on three of Wilson's criteria; 
whether screening can be performed on a continuous basis in general practice, 
whether the facilities exist in general practice to assess and follow-up those screened 
and whether screening is economically justifiable. 
In addition, two other areas of uncertainty which arc not defined by \Vilson's criteria 
exist and require further study; the applicability of the evidence on the efficacy of 
screening for older adults in primary care and the feasibility of screening programmes 
in every day practice 
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A cardiovascular health check in the elderly in general practice: 
does it offer new information and lead to interventions? 
CHAPTER. 2 
Introduction 
Cardiovascular disease is a major cause of death and disability in developed countries. 
Nowadays, an increasing number of persons suffer from cardiovascular disease, 
mainly because of reduced case fatality after myocardial infarction and the rapidly 
growing number of elderly. Primary and secondary prevention of cardiovascular 
disease focllsing on the elderly will become increasingly important. (I) 
Elderly men and women have a high absolute risk of cardiovascular events, (2, 3) and 
thus are liable to profit from interventions targeted at improvement of their 
cardiovascular risk profile. This is illustrated by the impressive results of trials on the 
treatment of hypertension in the elderly. (4, 5) However, these data do not necessarily 
translate to treatment in clinical practice. 
There is confusion over the role and type of screening in general practice to detect 
patients with unfavourable cardiovascular risk prol1les. General practitioners in the 
United Kingdom are obliged to perform a three-yearly cursory health check in adults, 
and to offer an annual comprehensive health check to those aged 75 years and over. 
Patients can be invited for this health check opportunistically as well as 
systematically. The cost-effectiveness of this general screening, including screening 
for cardiovascular risk factors, however, is still under debate. (6-9) 
In contrast, in the Netherlands cardiovascular screening is restricted to 
opportunistically measuring blood pressure or cholesterol level in patients with a high 
risk of cardiovascular disease. This approach may disregard some who might profit 
from antihypertensive treatment or cholesterol lowering. Even the implementation of 
such a restricted screening strategy may be hampered by the high workload in general 
practice. (10) 
Few studies have compared the relative merits of systematic and opportunistic 
cardiovascular screening in older adults. Holmen et al found that Norwegian GPs can 
detect and diagnose hypertension equally well with oppOliunistic screening and 
systematic screening. (II) On the other hand, McMenamin reported that in New 
Zealand, where opportunistic screening is advocated, offering a health check gave 
sufficient new findings to justify this effort. (12) Thus, it remains unclear which 
strategy a GP should choose to detect patients prone to develop cardiovascular 
disease. 
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The present study adds to this debate by examining the value of a systematically 
offered cardiovascular health check in general practice in the Netherlands, where 
selective opportunistic screening is advocated. \Ve investigated the number of 
previously unknown cardiovascular risk indicators that could be detected by a single 
cardiovascular health check of patients aged 60 years and over. It was also determined 
whether knowledge on some of these previously undetected risk factors led to further 
diagnostic or therapeutic interventions by the GP. 
Subjects and methods 
The study was performed in a general practice in Krimpen aan den IJssel, a suburban 
town near Rotterdam, from January 1991 until January 1992. Three GPs share the 
practice facilities. The GPs use computerised patient records as the main source of 
information about the health of their patients. AU medical data, including 
consultations, prescriptions, laboratory results and summaries of leiters from 
specialists. is recorded in the computerised patient file. A previous study showed that 
the computerised patient files were accurate in identifying 84% of all medication 
use. (13) 
All persons aged 60 years and over registered with this general practice received a 
letter from their GP, offering a single cardiovascular health check. This was followed 
by a telephone call from the research physician to arrange the health check. Those 
with dementia (n=20) or with a severe disabling illness (e.g. terminal malignancies) 
according to the general practitioner (n=80), did not receive an invitation. Participants 
of the pilot study (n=30) were also excluded. 
A research physician performed the cardiovascular health check. Firstly, the summary 
of the patient's medical history, which was made by the GP and recorded in the 
computerised patient file, was checked by the participant for its completeness. For 
example, if the GP had not included hypertension in the summary and the participant 
reported the use of antihypertensive medication, hypertension was added to the 
summary. Similarly, hypercholesterolaemia or diabetes mellitus could be added as a 
result of discussing the SUtllI}}(U-Y with the participant. Secondly, the health check 
consisted of a stmctured questionnaire and a physical examination. The questionnaire 
enquired about cardiovascular symptoms, diseases and family history, smoking and 
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drinking habits, and current medication use. The physical examination consisted of 
auscultation of hem1, major vessels and lungs, evaluation of peripheral pulsations and 
oedema, and palpation of the abdomen. In addition, blood pressure, glucose and 
cholesterol levels, heart rate, height and \veight were measured. 
Blood pressure was measured in sitting position with a standard desktop mercury 
sphygmomanometer; the mean of two readings with a one-minute interval was 
determined. Hypertension was diagnosed in accordance with the Dutch College of 
General Practice guidelines. (14) In participants with a diastolic blood pressure of ~95 
mm Hg, or a systolic blood pressure of ~160 111m Hg, two more sets of blood pressure 
values were obtained within the following 4 to 8 weeks. If the mean diastolic blood 
pressure of these sets was on average between 95 and 104 mm I-Ig, another two sets of 
measurements were obtained in the subsequent 4 to 8 weeks. In these latter parti-
cipants the mean of all five sets was taken as the blood pressure. Hypertension was 
defined as a mean diastolic blood pressure ~95 mm Hg, and isolated systolic hy-
pertension as a mean systolic blood pressure ~160 HUll Hg with a mean diastolic 
blood pressure < 95 mm Hg. 
Non-fasting capillary glucose levels were assessed by means of the Glucometer Gx 
(Amcs). If a capilJary glucose of 10 mmoJ/1 or higher was mcasured, a venous fasting 
sample was obtained. Diabetes mellitus was defined as a fasting sample above 6.7 
mmollL (15) Cholesterol level was determined only in pm1icipants with known 
hypertension, diabetes mellitus or hypercholesterolaemia as recommended by the 
Dutch College of General Practice guidelines. (16) This was done by a regional 
laboratory lIsing standardised techniques. In the present study a single total 
cholesterol level of 6.5 mmol/l or higher was required to diagnose 
hypercholesterolaemia. The body mass index was calculated as weightllenghe and a 
cut-off point of 30 kg/m2 was used to define obesity. 
For each pm1icipant the presence of the following risk indicators was assessed at the 
health check; hypertension, diabetes mellitus, hypercholesteroiaemia, smoking, 
obesity, a history of coronary heart disease in a first degree relative before the age of 
60 years, angina pectoris, intermittent claudication and a history of myocardial 
infarction, transient ischaemic attack or stroke. 
After the cardiovascular health check, a specially trained practice assistant and the 
research physician entered the risk indicators found at the health check in the patient's 
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computerised medical record at the general practice office. Subsequently the 
cardiovascular risk indicators found at the health check were compared with those 
mentioned in the summary of the patient's medical history in the computerised patient 
files. Each risk indicator which had been detected at the health check but was not 
mentioned in the summary was defined as newly found during the health check. 
In 1996 we systematically reviewed the patient records of all participants (n=llO) 
who, during the cardiovascular health check in 1991-1992, had been newly diagnosed 
with hypertension, diabetes or hypercholesterolaemia to assess \vhether diagnostic and 
therapeutic interventions were initiated within one year after the cardiovascular health 
check. Repeated measurements of blood pressure, glucose or total cholesterol levels in 
cases where one of these parameters was elevated during the cardiovascular screening 
examination, were considered diagnostic inten'entions. Therapeutic interventions 
were defined as the prescription of antihypertensive, antidiabetic or lipid-lowering 
dmgs. Because all participants with hypertension or hypercholesterolaemia had been 
given dietary advice by the research physician, this was not considered a therapeutic 
intervention initiated by the GP. Dietary advice in diabetes mellitus, however, was 
defined as a task of the GP. Therefore, dietary advice recorded in the patient file of a 
newly detected diabetic patient was considered a therapeutic intervention by the GP. 
DBase and the Statistical Package for the Social Science (SPSS) were llsed to store 
and analyse data. 
Results 
Of the 1132 registered persons aged 60 years or older, 1002 were invited. In total, 805 
subjects participated, giving a response rate of 80.3%. Non-responders (n;::;197) did 
not differ from responders in age and gender but \vere less likely to be insured by the 
National Health Service which indicates a higher social economic status. Most health 
checks (91 % ) were performed at the GP's office, and some were at the patient's 
hOllle (n=35) or nursing hOllle (n=39). 
The prevalence of cardiovascular risk indicators was considerable in this older 
popUlation. In 32% of the 805 participants one risk indicator was observed, in 27% 
two risk indicators, in 17% three risk indicators, and four or more risk indicators were 
found in 11 %. Only 13% of the participants were free from any of the cardiovascular 
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risk indicators included in the risk profile. Table 1 shows the cardiovascular risk 
profile of the participants, according to gender and age. 
Table 1. Prevalence (%) of cardiovascular risk indicators during a single cardiovascular screening 
examination of 805 persons 2 60 years in general practice. n :::::: number of patients. 
Cardiovascuhu' risk indicator Men 'Vomen 60-69 yl'S >70 yrs tofal 
11=379 n=426 n=526 n=279 n=805 
Hypertension 25.7 33.4 27.6 33.8 29.8 
Isolated systolic hypertension 9.0 11.3 6.9 16.6 10.2 
Diabetes mellitus 6.6 8.0 4.6 12.5 7.3 
Cholesterol;:;: 6.5 mmoll1 22.2 29.1 30.2 17.6 25.8 
CUrrent cigarette smoking 31.5 12.5 24.1 16.5 21.4 
Body Mass Index;:;: 30 kg/ml 6.6 15.3 10.1 13.3 11.2 
Family history of cardiovascular disease 19.6 21.8 22.4 17.6 20.7 
Angina pectoris 11.4 11.5 8.0 17.9 11.4 
Intermittent claudication 5.3 1.6 2.9 4.3 3.4 
History of myocardial infarction 12.1 5.9 6.7 12.9 8.8 
History of transient ischaemic attack 5.3 3.1 3.4 5.4 4.1 
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Risk indicators previously unknown to the GP were found in 25.1 % of the participants 
(Figure I), including 38 (4.7%) cases of hypertension, 82 (10%) cases of isolated 
systolic hypertension, 14 (1.7%) cases of diabetes mellitus and 63 (7.8%) cases of 
hypercholesterolaemia. Furthermore, 8 (1 %) participants suffered from angina 
pectoris and to (1.3%) from intermittent claudication, while these complaints were 
not known to their GP. In addition, the summary of the participant's medical history 
contained no information on cigarette smoking (n= 172), family history of 
cardiovascular disease (n=166) or obesity (n=89). If these three latter risk indicators 
are taken in account, 59% of all participants had at least one risk indicator which was 
not recorded in the summary of the patients medical history. 
Figure 1. Prevalence of cardiovascular risk indicators known from the general practitioner's normal 
care case finding and newly detected risk indicators during a single health check in 805 participants. 
No diagnoses of isolated systolic hypertension (ISH) were included in the general practitioners 
summary of the patient's medical history. 
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In almost all participants with newly diagnosed diabetes mellitus the GPs gave dietary 
advice (n=4) or started medication (n=3) (Table 2). These diabetic patients had no 
complaints of diabetes mellitus recorded in their patient file and treatment was started 
only because of the repeatedly elevated glucose levels found at the health check. Of 
25 patients with previously unknown hypertension, treatment was initiated in 6 
pmiicipants only, while fmiher diagnostic measurements of the blood pressure took 
place in as few as 5 cases. The GPs hesitated to actively manage 
hypercholesterolaemia. The cholesterol level was measured again within one year in 
II of 48 participants with a single cholesterol measurement above 6.5 mmolll, while 
in I patient lipid-lowering medication was prescribed. 
Table 2. Number of interventions (%) within one year after hypertension, diabetes mcllitus or 
hypcrcholcslerolaemia detected during a single cardiovascular health check. 
Cardioyascular 
indicator 
risk Number of Diagnostic 
cases detected infcn'cntions 
Hypertension 25 5 (20) 
Diabetes mellitus 8 0(0) 












Screening for cardiovascular risk indicators aims at detecting subjects ,vilh 
unfavourable risk profiles and preventing the occurreJlce of coronary hemi disease or 
stroke. This may be even more relevant in the elderly, who are at a higher risk of such 
events. During a cardiovascular health check of 805 men and women aged 60 years 
and over, we found cardiovascular risk indicators that were previously undetected by 
the GP in 25.1 % of the participants. Although detection of diabetes almost always led 
to therapeutic actions by the GP, previously unknown hypertension and elevated 
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cholesterol levels did not initiate diagnostic or therapeutic interventions in the 
majority of cases. 
A health check in all subjects enlisted in a general practice is not the advocated 
method in the Netherlands to detect unfavourable cardiovascular risk profiles. Rather, 
the Dutch Collegc of General Practitioners guidelines recommend that GPs actively 
screen for hypertension or hypercholesterolaemia only when they are consulted by 
patients with at least one other cardiovascular risk indicator. Because risk indicators 
tend to cluster and because their harmful impact increases exponentiaJly when other 
risk indicators are present, this case finding of high-risk patients is considered to be 
cost-effective. However, as our study shows, this advantage must be balanced against 
the disadvantage of having incompletc information on the prcsence of modifiable 
cardiovascular risk indicators in a large proportion of elderly in general practice. 
Our study has a number of limitations. First, it is obvious that the end-point chosen in 
this study, i.c. the number of newly detected risk indicators, depends on pre-existent 
efforts and interests of the GPs in preventive cardiology. With only three GPs from 
one practice participating in this study, the higher than average interest of the 
participating GPs in preventive cardiology could havc led to a smaller number of 
newly detected cardiovascular risk indicators. Another limitation is that the study was 
conducted in 1991-1992; new reports on the therapy of isolated systolic hypertension 
and hypercholesterolaemia have led to more active intervention policies being 
advocated. (4, 5, 17, 18) 
The lack of diagnostic or therapeutic actions of the GPs following a single increased 
cholesterol level in our study is understandable. The efficacy of lipid lowering in the 
elderly was debated during the time our study was performed. (15, 19) However, 
more recent studies suggest that treatment is cffective up to 64 years in patients 
without myocardial infarction and up to 70 years in patients with myocardial 
infarction. (17,18) 
In our study population, hypertensives were not always treated. This finding concurs 
with other reports, indicating that GPs are hesitant to treat hype11ension in the elderly 
and only do so if blood pressure values are significantly higher than the cut-off value 
for treatment advised in the guidelines and used in the present study. (20-22) 
Nevcl1hcless, the evidence provided by the recent trials on the favourable effect of 
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treating hypeltension and isolated systolic hypertension in the elderly will probably 
reduce the proportion of untreated elderly hypertensive patients. (23) 
Although a recent report suggested an increase in case finding for diabetes mellitus by 
Dutch GPs in the last decade, 1 % of patients in our study still had undetected diabetes. 
(24) Fortunately, the GP initiated treatment in almost all cases. 
Large studies comparing the effectiveness of selective opportunistic screening and 
more extensive systematic screening for cardiovascular risk indicators in the elderly, 
are scarce. (11, 12) The OXCIIECK and the British Family Heart study, which included 
younger pmticipants up to 64 and 59 years, respectively, showed only modest effect 
of systematic screening and subsequent intervention on the cardiovascular risk profile. 
Their results add to the debate on whether the costs of cardiovascular health checks on 
such a large scale can be justified in view of other health care expenditures. (7, 25, 26) 
Calculations based on the OXCHECK l1ndillgs and the Framingham data showed a 
greater cost effectiveness of more selective forms of screening, slich as a strategy 
targeted at hypertensive men in their seventh decade of life. (27) 
\Ve conclude that a single cardiovascular health check in the elderly may identify risk 
indicators which are not recorded in the patient file. In the general practice setting of 
the present study, these risk indicators were not detected by the normal care selective 
opportunistic screening. These gains should be balanced against the costs of this 
health check, which amount to £30 per participant. Furthermore, the lack of 
interventions in elderly hypertensive and hypercholesterolaemic patients indicates that 
more effort is needed to ensure that the beneficial effects following risk factor 
intervention are not limited to participants in clinical trials but can be extended to 
patients in general practice. 
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Among the elderly, first manifestations of cardiovascular disease may cause 
dependency or death. To prevent or postpone these endpoints, knowledge of the 
cardiovascular risk profile is elementary. (1) A general practitioner can increase this 
knowledge above the level achieved by normal care alone by using screening or case 
finding strategies. 
In a screening programme, subjects are asked to attend a preventive examination at 
the general practitioner's office, whereas in case finding or opportunistic screening 
preventive services are offered during routine visits. In an earlier study we assessed 
the value of a single screening examination among elderly patients in general practice. 
\Ve observed previously unknown (Le. not detected through normal care and case 
finding) hYPCliension, isolated systolic hypertension, diabetes mellitus and 
hypercholesterolemia in a considerable proportion of patients (25%). (2) 
To keep an individual's cardiovascular risk profile lip to date repeated cardiovascular 
health checks may be of value. In the United Kingdom, general practitioners are 
advised to perform a health check triennially, including an assessment of 
cardiovascular risk indicators, in patients up to 75 years. In patients above this age, 
health checks are to be performed yearly, but do not include measurements of the 
cardiovascular risk profile. (3) These frequencies, however, are chosen rather 
arbitrarily. (4, 5) The ideal frequency, as determined by its effectiveness in finding 
information that may alter subjects preventive management, lacks sUpp0l1 from 
empirical evidence. 
In the present study, we addressed this issue by repeating a cardiovascular health 
check in an elderly cohort after 5 years. We assessed the value of the repeated health 
check by comparing risk indicators detected at the second health check with the 
information known to the general practitioner. i.e. obtained during normal care and 
case finding activities and at the first health check. 
Methods 
The study was performed in one general practice with three general practitioners in 
Krimpen aan den IJssel, a suburban town near Rotterdam, the Netherlands. During the 
study period, one general practitioner retired and was replaced by a younger 
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colleague. Pm1icipants received two consecutive cardiovascular health checks, one in 
1991 and one in 1996-1997. The time between these two investigations ranged from 
4.3 years to 6.4 years. 
Details of the first health check in 1991 were reported elsewhere. (2) In brief, all 
enlisted patients aged 60 years and over, who were not suffering from terminal 
diseases or dementia, were invited for a cardiovascular screening examination at the 
general practitioner's office. The methods applied to recmit participants and measure 
cardiovascular risk indicators in the second health check were similar to those of the 
first health check. In addition, in the second health check the ankle/arm index \vas 
measured (6, 7) and a twelve-lead electrocardiogram was made and analysed by the 
complller programme MEANS. (8) 
Pm1icipants of the first health check were invited by a letter from their general 
practitioner to participate in a repeated cardiovascular health check. Patients with 
terminal diseases or dementia were not invited. Non-responders received a repeated 
invitation near the end of the study period. Patients who still chose not to participate 
were asked by telephone to provide a reason. 
A research physician assisted by three specially trained medical students performed 
all cardiovascular health checks. Medication use and the presence of cardiovascular 
risk indicators were assessed by a structured questionnaire, which included the Rose 
questionnaires to establish the presence of angina pectoris and intermittent 
claudication. (9) A positive family history for cardiovascular disease was defined as 
having one or more first-degree relatives under the age of 60 with angina pectoris, 
myocardial infarction, sudden death or stroke. 
Physical examination included measurements of height, weight and pulse rate, 
auscultation of the heart, major vessels and the lungs, evaluation of peripheral 
pulsations and oedema, and palpation of the abdomen. Blood pressure was measured 
in sitting position with a standard desktop mercury sphygmomanometer. The mean of 
three readings with a one-minute interval was determined. Hypertension and isolated 
systolic hypertension were defined according to the guidelines of the Dutch College 
of General Practitioners.( 10) In these guidelines, isolated systolic hypertension is 
defined as a systolic blood pressure above 160 mmHg combined with a diastolic 
blood pressure below 95 mmHg. Patients with elevated blood pressure were offered 
three additional appointments with three readings, each within the following 3-6 
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weeks. Both baseline and follow-up measurements were used to calculate the mean 
blood pressure. 
The Glucometer Ox (Ames) was used to measure non-fasting capillary glucose levels. 
A repeated measurement was performed in those whose initial measurement was 11.1 
mmolfl or higher. Diabetes mellitus was diagnosed if the mean of these non-fasting 
glucose samples exceeded 11.0 mmoi/l. (II) According to the cholesterol guidelines 
of the Dutch College of General Practitioners, total cholesterol level was determined 
in patients with a diagnosis of hypertension, diabetes mellitus or hypercholesterolemia 
only. (12) To analyse the capillaty blood specimen the desktop analyser Lipotrend(13) 
was used. All subjects with capillary cholesterol above 6.4 mmolll were offered a 
determination of the senUll cholesterol level and this was obtained in 37% of the cases 
with capillary cholesterol above 6.4 tllmolli. Hypercholesterolemia was defined as a 
single, or, if available, mean total cholesterol of 6.5 ml110111 or more. 
The presence of all cardiovascular risk indicators observed at the repeated 
cardiovascular health check was recorded. To determine whether a risk indicator was 
already known to the general practitioner at the time of the repeated health check, a 
systematic search of the information available in the computer-based patient records 
of all patiicipants was made. The study practice used the computerised patient file 
since 1991 to record all data on medical history, consultations, prescriptions and 
abstracts of letter from specialists; no other sources of recorded infonnation exist to 
guide the management of patients in tllis study practice. 
Hypertension and isolated systolic hypertension were considered to be known if the 
participant had been prescribed antihypertensive dl1lgs, or if such a diagnosis was 
mentioned in the patient file together with elevated blood pressure values. A diagnosis 
of diabetes mellitus was considered to be known by the general practitioner if the 
patient file mentioned the diagnosis, or if insulin or oral antidiabetic dl1lgs were used. 
A diagnosis of hypercholesterolemia at the repeated health check was considered 
previously known by the general practitioner if the participant's file mentioned either 
the prescription of lipid-lowering dmgs or at least one total cholesterol measurement 
exceeding 6.5 mmolll, or a diagnosis of hypercholesterolemia. 
After the cardiovascular health check, the practice assistants and the research 
physician entered the risk indicators for each participant in the patient record at the 
general practice office. Participants received a letter including the results on 
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modifiable risk indicators hypertension, isolated systolic hypertension, diabetes 
mellitus, hypercholesterolemia, smoking and adiposity. If necessary t they were 
advised to visit their general practitioner. 
Results 
Table 1. Prevalence (%) of cardiovascular risk indicators during the initial health chcck (1991) in 
participants of a repeated health check in 1996 (n=509), in non-responders of the repeated health check 
and in those who died or moved between the two health checks or were excluded for the repeated 






Age 60-69 years 76.6 
70-79 years 19.8 
>= 80 years 3.3 
Gender (% male) 48.9 
Hypertension 20.8 
Diabetes mellitus 3.1 
Hypercholesterolemia 19.8 
Smokers. 20.0 
Angina pecioris 9.0 
l"'(yocardial infarction 6.5 
Stroke 0.2 
Transient ischemic attack 2.8 
Intermittent claudication 0.6 
Collective health 38.5 
insurance 
Non-Responders Died between 

































Of the 805 patients who participated in the first health check, 509 (63%) participated 
in the repeated health check. In the five-year interval between the health checks, 100 
subjects had died, 52 had moved to another area or general practitioner, and 4 ,,,ere 
not registered with the practice for unknown reasons. Furthermore, 6 patients who 
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suffered from a terminal illness and 8 patients with dementia \vere not invited. The 
response rate among the 635 eligible patients was 80%. Reasons not to attend were 
listed among 47 (37%) non-participants and included no motivation (n=27), treatment 
by specialist (n=II), old age (n=5) and other reasons (n=4). 
Responders were younger and had a lower prevalence of cardiovascular disease, 
hypertension and diabetes mellitus at the first health check than non-responders or 
those who had died or moved between the health checks (Table I). In addition, the 
number of individuals insured by the National Health Service \vas relatively low, 
indicating a higher social economic status. The prevalence of cardiovascular risk 
indicators observed at the repeated health check is shO\vn in Table 2. 
Tflble 2. Prevalence of cardiovascular risk indicators among participants (n=509) at the repeated health 
check. ~'Iean age was 71.6 (SO; 5.2) years. 
Cardiovascular risk indicator 
Hypertension 
Isolated systolic hypertension 
Diabetes mellitus 
H Y percholestcrole III ia 
Smoking 
Obesity (B1U :-::; 30.0) 




Transient ischemic attack 
Intermittent claudication 













In 14.5% of all participants the health check detected at least one modifiable risk 
indicator not present in the general practitioner's patient file (Table 3). Isolated 
systolic hypertension was the most frequently encountered unknown risk indicator. 
However, after subtraction of risk indicators that were already diagnosed at the first 
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health check but apparently not adequately followed-up by the general practitioner, 
new information was found in 9% of the subjects only. 
Table 3. Prevalence (%) of cardiovascular risk indicators observed at the repeated health check; 
categorised according to whether or not they were mentioned previously in the patient file at the 
general practice office or whether or not they were already observed at the first health check. (n=509). 





Isolated systolic hypertension 
Diabetes mellitus 
Hypercholesterolemia 
Obseryed at repeated health check 






Obsen'ed at first Not observed at 










Modifiable risk indicators diagnosed during the repeated health check but already 
known to the general practitioner, were found in 19.8% of the participants (Table 3). 
The majority of these cases consisted of subjects with known hypercholesterolemia in 




This study is, to our best knowledge, the first to assess the value of a repeated 
cardiovascular health check in the elderly in general practice. New information for the 
general practitioner about modifiable risk indicators, notably isolated systolic 
hypertension, was observed in 14.5% of the participants. However, about 40% of 
these risk indicators were already detected at the first health check five years earlier. 
The response rate of 80% in our study is comparable to that achieved in the younger 
population of the OXCHECK study. However, the fact that those with a more 
beneficial cardiovascular risk profile attended the health check more often decreases 
its potential effectiveness. (14, IS) 
The value of the repeated cardiovascular screening among the oldest subjects in our 
cohort was limited. Of those alive after 5 years, only 58% of the elderly who were 75 
years and over during the first health check attended the second examination. This 
implies that in the oldest subjects other methods leading to higher participation rate 
(e.g. by offering home visits) and more tailored to the needs of the elderly should be 
applied. (16) The results of the limited number of studies taking this approach, 
however, are conflicting. (l7-20) 
Our study connrms the idea that isolated systolic hypertension in the elderly is 
underdiagnosed by general practitioners. (21-24) The revised guideline of the Dutch 
College of General Practitioners on hypertension was published after our study and 
explicitly states that blood pressure in the elderly should be measured 
opportunistically eaeh year. Implementation of this and similar guidelines will reduce 
the proportion of elderly with undiagnosed isolated systolic hypertension. (25) 
Our prevalence of hypercholesterolemia (13.6%) should be interpreted with care. In 
the five years between the health checks, new evidence from secondary prevention 
trials concerning the effectiveness of treatment with statins in elderly up to 70 years of 
age has emerged. (26, 27) Guidelines have long been contradictory about whether or 
not to treat elderly with hypercholesterolenlia. (28, 29) According to the revised 
guideline of the Dutch College of General Practitioners on hypercholesterolenlia, to 
be published in 1999, only 5 of the 69 patients with hypercholesterolemia that were 
detected in our study would require treatment with lipid-lowering agents. 
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Our study has a number of limitations. Firstly, benefits were expressed as the 
detection of unknown modifiable risk indicators and other potential endpoints, notably 
morbidity or mortality reduction, were not included. The prop0l1ion of risk indicators 
unknown to the general practitioner is, however, an acceptable endpoint since the 
evidence concerning the effectiveness of some preventive interventions in the elderly, 
e.g. antihypel1ensive treatment, is beyond doubt. Secondly, the motivation of the 
participating general practitioners (n=4) in ollr study practice to detect cardiovascular 
risk indicators in day-to-day practice may be relatively high. Tilis will decrease the 
number of unknown cardiovascular risk indicators that can be found at a health check 
and underestimate its benefit. Thirdly, regression to the mean could overestimate our 
findings. The number of measurements performed among our participants to diagnose 
hypertension or hypercholesterolemia is lower than recommended. (30) 
Although our repeated screening detected previously unknown cardiovascular risk 
indicators in 14.5% of the participants, about forty percent of the risk indicators were 
already observed at the first health check. Clearly. identification of risk is not enough 
to guarantee a beneficial change in a patient's risk profile. (31) Attention given at 
intervention after screening is of paramount importance for screening to be successful. 
The most important outcome of the repeateci cardiovascular health check was the 
finding of isolated systolic hypertension in 47 participants. Treatment of these patients 
for llve years may prevent a major cardiovascular event in approximately 2.5 patients 
and stroke in 1.4 patients. (3.2, 33) The total cost of ollr programme was estimated as 
£14,650, i.e. £28.8 per participant. These costs and the workload associated with 
repeated systematic screening and its follow-up measurements make repeated health 
checks, as performed in our study, not feasible in general practice. Fm1hermore, the 
cost effectiveness of our health check contrasts sharply with the cost effectiveness of 
blood pressure measurements during opportunistic screening in normal care. (34-36) 
Therefore, rather than repeated health checks, optimisation of case finding, notably 
directed at isolated systolic hypertension, should be pursued. Apparently, general 
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The potential of cardiovascular drug review in older people 
CHAPTER 4 
Introduction 
Older people are important dmg consumers. In the Netherlands, two thirds of older 
men and women lise at least one prescribed medication (I). Furthermore, these 
numbers are likely to increase, as the population is ageing and indications for drug 
treatment in older people are expanding. Cardiovascular dl1lgs are among the most 
frequent prescribed dmgs in this age group. (2). 
Optimising cardiovascular drug therapy in older people can be difficult (3, 4). It is 
estimated that 28% of admissions of older people to acute care centres in the US is 
caused by adverse events or nOll-compliance, often related to cardiovascular dmgs (5). 
Because these problems may be preventable (6, 7), the Royal College of General 
Practitioners in the UK and others advocated an annual review of the medication use 
of older people by their primary care physician (8-12). However, quantitative 
assessment of the benefits of such an intervention is lacking. 
General practitioners (GPs) in the Netherlands are in a unique position to monitor the 
medication use by older adults. The central role of GPs in the health care system, 
continuity of care, the increasing use of computer-assisted prescribing and the co-
operation of pharmacists and the availability of numerous clinical guidelines all 
enhance the GP's ability to prevent inappropriate usc of medication by older patients. 
Therefore, it could be argued whether a regular review of the medication use of older 
people in primal}1 care offers additional value. 
\Ve addressed tllis issue by reviewing the use of cardiovascular medication in older 
persons enlisted in one group practice in the Netherlands. Emphasis was on the dose 
of the dmgs prescribed and on the adherence of the prescription to the guidelines of 
the Dutch College of General Practitioners. Furthermore, we determined whether the 
GP had a complete overview of all the drugs llsed by their older patients. 
Methods 
The medication review was performed in one group practice with three partners in 
Krimpen aid JJssel, a suburban town near Rotterdam, the Netherlands. The GPs of the 
study practice have been using computer-assisted prescribing since 1990. This means 
that evelY prescription is checked by the computer regarding double medication, 
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interacting medication, contra-indications and high doses, based on a medication 
dalabase developed by Ihe Dulch Royal College of Pharmacy (13). FUl1hermore, Ihe 
computer checks the interval between repeated prescriptions to detect possible under-
or ovemse of medication. Almost all drugs prescribed in tltis practice are obtained at 
two pharmacies. The pharmacists monitor the prescription similar to the computer 
check and contact GPs in case of doubtful prescriptions. Peer review meetings 
between pharmacists and GPs are organised every 6 weeks as a Illeans of continuing 
education on pharmacotherapy. 
The medication review was part of a larger survey aimed at determining the 
effectiveness of single and repeated cardiovascular health checks among the elderly. 
(14) and was performed in 1996. A 10lal of 560 elderly men and women, aged 64 
years and over, participated. They comprised 80% of those participants of the first 
health check in 1991 who were slill eligible in 1996 (n=509), pins a small group of 
spouses of participants (n:::::22) or patients who had been eligible and willing to 
participate in the first health check but had not pm1icipated due to various reasons 
(n=29). 
All participants were interviewed by a research physician (PJB) at the OP's oHice. 
They were asked to bring containers of every dmg they used. All prescription and 
non-prescription dl1lgs that were used during the previous 14 days were recorded. The 
generic or non-generic name of the drug was classified by means of the Anatontical 
Therapeutic Chemical (AT~) classification index (15). Cardiovascular medication 
was defined as medication with an ATC coding starting with 'c'. 
Infoffilation on the dose that the patient actually used and the prescriber, if it was not 
an over-the-counter dmg, was obtained. Drug containers or medication charts could 
serve as a reminder for the participant. To gain insight in the perceived indication for 
the dmg therapy by its users the participants were asked the indication for each drug 
by answering the question '\Vhy do you use this drug?' Their answers were 
categorised in specific and non-specific categories, e.g. 'for angina pectoris' or 'for 
the heart'. 
After the screening exantination, the computerised patient files at the OplS office of 
the 209 participants who reported the use of cardiovascular medication were audited. 
The prescriptions recorded in the patient file were compared with the use reported by 
the patient. Of the medications present in the patient file the prescribed doses were 
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recorded. These doses were compared with the minimum effective doses as 
determined in the Dutch National Formulary (16). Preferably, a specific minimum 
dose for the elderly was llsed for this comparison. but if this was not available the 
minimum dose for adults was used. 
Medications that could interact with cardiovascular medications were identified by 
lIsing the Dutch National Formulary. For each participant who reported the use of 
cardiovascular medication, all other used dmgs mentioned in their interview were 
assessed to identify possible interactions. 
We reviewed the guidelines on hypertension, angina pectoris and heart failure of the 
Dutch College of General Practitioners (17-19) to identify drugs of first, second and 
third choice for these conditions. The indication for treatment with cardiovascular 
dmgs was determined through assessment of the computerised patient files by the 
research physician. When the patient file was inconclusive or in case more than one 
indication was mentioned, one of the prescribing GPs (AP) was asked to clarify this 
issue. 
Results 
Participants (n=560) reported a high usc of cardiovascular medication (Table I). Only 
dl1lgs of the alimentary tract were used more often, mainly due to the self~deterI1lincd 
use of vitamin preparations. In 34% of men and 41% of women at least one 
cardiovascular dmg was used. Participants who used cardiovascular dmgs (n=209) 
also used more dmgs simultaneously (mean 3.6) than users of medications other than 
cardiovascular dmgs (mean 2.2). 
Almost all cardiovascular medication mentioned by the patient (92%) was recorded in 
the computerised patient file. Medication· that was missing from the patient file 
included sllOIi-acting nitrates (n=8), diuretics (n=6), P-blockers (n=6), calcium 
antagonists (n=3) and ACE inhibitors (n=3). Medication the patient reported to be 
prescribed by a specialist was most likely to be missing from the patient file; in 14% 
of specialist prescriptions there was no record in the patient file. 
Table 1. Numbers (n) and percentages (%) of all reported medication use in older men (n=273) and 
women (n=287), categorised according to ATe coding. 
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~Iedicn(jon clnss (ATe coding) Men Women All 
n=273 n=287 n=560 
n % n % n % 
Alimcntary tract and mctabolism (A) 86 31.5 129 44.9 215 38.4 
Cardiovascular system (C) 92 33.7 117 40.8 209 37.3 
Nervous system (N) 44 16.1 89 31.0 133 23.8 
Blood and blood-forming organs (B) 62 22.7 54 18.8 116 20.7 
l\'lusculoskeletal system (1\'1) 25 9.2 29 10.1 54 9.6 
Respiratory system (R) 24 8.8 26 9.1 50 8.9 
Sensory organs (5) 12 4.4 20 7.0 32 5.7 
Dermatologies (D) 21 7.7 8 2.8 29 5.2 
Genitourinary system (G) 6 2.2 12 4.2 18 3.2 
Hormonal preparations (H) 4 1.5 13 4.5 17 3.0 
General anti-infectives (1) 0.'1 4 1.'1 5 0.9 
Antineoplastic agents (L) 0.4 0.3 2 0.4 
Any medication 188 68.9 236 82.2 424 75.7 
No medication 85 31.1 51 17.8 136 24.3 
The prescribed dose, recorded in the patient me, was below the minimum effective 
dose in 19% of prescriptions. On average, however, our participants llsed a dose 
\vhich was almost 40% higher than the defined minimum dose. 
In 18% of all cardiovascular medications used by the participants, interacting 
medication was present. The class of drugs most frequently involved in drug-drug 
interactions were diuretics (Table 2). The agents which caused most interactions with 
cardiovascular medications were non steroidal anti-inflammatOlY drugs (NSA1Ds); 
the majority of NSAJDs used were over-the-counter drugs. A qualitative description 
of the most frequent interactions and their effects can be found in Table 3. 
Table 2. Numbers (n) and percentages (%) of prescriptions for cardiova~cular medication (n;;:253) 




































Table 3. ~'Iost frequently recorded combinations of interacting medications among the 209 users of 
cardiovascular medications (n= 253 prescriptions). 
Interacting mcdications 
B-Blocker NSAID 
ACE inhibitor Diuretic 
Digoxin Furosemide 
Diuretic NSAID 













diminished effect of antihypertensive treatment 
hypotension 
increased risk of intoxication by glycosides 
diminished effect of antihypertensive treatment 
diminished effect of antihypertensive treatment 
and hyperkalemia 
increased potassium loss 
hypotension, atrioventricular conduction delay, 
left ventricle dysfunction 
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The type of drugs used for the treatment of hypertension, angina pectoris and heart 
failure differed considerably from the lype of drugs recommended in the guidelines of 
the Dutch College of General Practitioners (Table 4). A first choice dmg was used by 
28%, 41 % and 73% of the persons treated for hypertension, angina pectoris and heart 
failure, respectively. In 3% of the cases, a drug was contra-indicated. For example, 
two patients were using P-blockers together with medication to treat their chronic 
obstmctive pulmonary disease. 
Table 4. Number (n) and pcrcentages (%) of patients with hypertension (n=123), angina pectoris 
(n=46) and heart failure (n= II) who are treated with first, second, third choicc or contra-indicated 
drugs, according to the guidelines of the Dutch College of General Practitioncrs. 
!\Iedication Hypertension Angina Pectoris Heart fnilure 
n=123 n=46 n=11 
n % n % n % 
Use of: 
I" choice drugs 34 27.6 t9 41.3 8 72.7 
2&J choicc drugs 6t 49.6 t6 34.8 2 t8.2 
3fJ choicc drugs 25 20.3 8 t7.4 9.1 
contra indicntcd drugs 3 2.4 3 6.5 0 0 
Patients were not always aware of the reason their GP or specialist prescribed the drug 
(Table 5). Although 78% correctly reported to use antihypertensive medication for 
hypertension. only 35% of heart failure patients knew the purpose of their medication. 
Discussion 
In this study we investigated whether a review of cardiovascular medication of older 
people is fmitful in a primary care practice in the Netherlands where many conditions 
for strict medication control are met. To our knowledge, no other study has addressed 
this issue. 
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Table S. Comparison of the indication according to the patient file and mentioned hy the patient 
among users of drugs for hypertension, angina pectoris, heart failure and atrial fibrillation. 
Indications according 10 Indicatiolls according to patient 
patient tile 
similar to other than unknown 
patient tile patient tile 
n 11 % 11 % n % 
Hypertension 144 113 78.5 29 20.1 2 1.4 
Angina pectoris 95 54 56.8 35 36.8 6 6.3 
Hearl failure 20 7 35.0 12 60.0 5.0 
Atrial fibrillation 19 10 52.6 9 47.4 0 0.0 
By means of computerised patient files, the participating GPs had an almost complete 
overview of the medication use of their patients. Prescriptions initiated by specialists, 
however, were not recorded in the patient file in 14% of the cases. Extra care is 
needed to ensure prompt reporting of these data by the specialist or pharmacist to the 
GP. The expanding possibilities of electronic communication may assist in this task. 
Our estimates of the prevalence of prescribing below the minimum effective dose 
should be interpreted carefully. A specinc minimum dose for the elderly was not 
always mentioned in the Dutch National Formulary. Furthermore, some patients may 
have lIsed lower doses because of combinations with other dmgs. Nevertheless, it is 
unlikely that these nlctors will fully explain the 19% of the prescriptions that were 
below the minimum effective dose. Studies on undemse of medications in the elderly 
are seldom performed (20). Medication reviews offer the opportunity to question 
whether drugs at these low dosages exert the desired effect and whether dosage 
adjustments or cessation of medication use is appropriate (21, 22). 
In our study practice, where both the computer system and the pharmacist warn the 
GP in case the drug prescribed interacts with other medication, in as much as 18% of 
all prescriptions interacting dmgs were involved. This was mainly due to the use of 
over-the-counter drugs, notably NSAIDs, which are not recorded in the patient me 
(23). Among dntgs which were recorded in the patient file, only a small number of 
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combinations, such as digoxin and diuretics (n=6), diuretics and prednison (n:::2) and 
diltiazem and B-blockers (n=I), were liable to cause a serious drug interaction (24). 
Furthermore, awareness of interactions is more important than absolute avoidance of 
combinations of interacting medications. 
The discrepancy we found between drugs advised in guidelines and those used in 
practice, e.g. for the treatment of hypertension, has been reported before (25). A 
medication revie\v may serve as an opportunity to adjust the type of prescribed drugs 
to the current guidelines. However, a lack of consensus between GPs and specialists 
on the preferred type of dmgs may impede this. General practitioners may repeat 
prescriptions of medication initiated by a specialist, which are only second or third 
choice dmgs according to the guidelines developed for general practice. Furthermore, 
the benefit of prescribing a first choice dmg should be large enough to justify a 
change in an individual patient's drug regimen (26); this is often open to debate. 
Nevertheless, a medication review can act as a barrier against the uncritical use of 
second and third choice cardiovascular drugs among older people (27). 
Our study showed that patients who use cardiovascular medication were not always 
aware of the reason for prescription. The literature on this subject is conflicting, 
possibly because of the methods used to test the knowledge of patients about their 
drugs (28). \Ve asked our pm1icipants the simple question '\Vhy do you use this 
dmg?' If a GP adds this question to his medication revie\v, he must have ample time 
to discuss the answers of his patients. However, this might be worth the effort since 
better understanding might lead to better compliance, and the consequences of non-
compliance with cardiovascular medication may be serious (5). 
Some limitations of our study have to be mentioned. Firstly, a research physician 
determined most of the indications for medication use by means of the computerised 
patient file. This requires the patient file to be complete. Although in case of doubt 
one of the GPs was asked to provide the indication, misclassification could have 
occurred. Secondly, questions about side-effects and compliance were not included in 
our medication review. Thirdly, the revised guideline on hyper1ension from the Dutch 
College of General Practitioners we used was not yet published at the time we 
conducted our study. However, this guideline reflects knowledge which was already 
available from the literature and was partly incorporated in the previous guideline, 
published in 1991. 
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\Ve conclude that regular review of cardiovascular medication is valuable, even in 
gcnentl practices where Jllany conditions to adequately monitor medication lISC arc 
met. In particular, dosages below the minimum effective dose, low adherence to 
guidelines and patients' lack of knowledge about the indication for their drug are 
issues that could be addressed at a yearly medication review of older users of 
cardiovascular medication. Since these patients visit their GP regularly, this could be 
done opportunisticaHy during routine consultations, provided that the patient is 
notified to bring all dmg containers to the GP's office. Prescribing cardiovascular 
medication does not end with signing the prescription; active monitoring is 
mandatory. 
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Is electrocardiography a useful screening test in general practice? 
CHAPTER 5 
Introduction 
Electrocardiography is frequently used in clinical practice for the diagnosis and 
management of heart disease. In the Netherlands, general practitioners have easy and 
rapid access to this facility, either because they own an electrocardiograph themselves 
or because they can use medical laboratory- and hospital-based services. 
Electrocardiography is especially valuable in the analysis of complaints of 
palpitations or chest pains. (l, 2) In addition, a general practitioner may consider to 
use the electrocardiograph in asymptomatic patients as a tool to guide in 
cardiovascular risk stratification. (3) 
The use of the EeG for screening purposes in asymptomatic middle aged men is 
considered not useful. (4-6) In the elderly, however, EeG abnormalities have a more 
pronounced prognostic importance for future cardiovascular events. (7-11), while the 
prevalence of electrocardiographic abnormalities is higher. (10) Detection of several 
of these EeG abnormalities, notably silent infarctions, left ventricular hypertrophy 
and atrial fibrillation, could have therapeutic implications. Thus, screening for these 
abnormalities may beneficially influence prognosis. 
In this study, the value of electrocardiographic screening, in terms of detection of 
previously undiagnosed atrial fibrillation, left ventricular hypertrophy and silent 
infarctions, is examined. The prevalence of these newly detected electrocardiographic 
abnormalities, and some additional EeG abnormalities with established prognostic 
significance, is repOlied. Furthermore, we determined whether electrocardiographic 
screening would be more valuable when targeted at cel1ain subgroups of older people, 
notably those with hypertension or diabetes. 
Methods 
The general practice office where the study was performed was located in Krimpen 
aid IJssel, a suburban town near Rotterdam. Electrocardiographic screening was prui 
of a larger study on the effectiveness of single and repeated cardiovascular health 
checks in the elderly (12) and was performed in 1996, during the repeated screening 
examination of participants of a first health check in 1991. Five hundred sixty elderly 
Illen and women, aged 64 yenrs and over, participated. They comprised 80% of those 
pm1icipants of the first health check in 1991 still eligible in 1996 (n=509), and a small 
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group of spouses of participants (n=22) or patients who had been eligible and willing 
to participate at the first health check but had not participated because of various 
reasons (n=29). Of all participants at the repeated health check, cardiovascular 
complaints, medical history and use of medications was recorded and blood pressure, 
capillary cholesterol and glucose concentrations were measured. 
The ECGs were recorded with an ACTA electrocardiograph (ESAOTE, Florence, 
Italy) at a sampling rate of 500 Hz. All ECGs were stored digitally and interpreted by 
the Modular ECG Analysis System (MEANS). The MEANS program has been 
evaluated extensively. (3) It provides several ECG diagnoses, often including an 
indication of the certainty of the diagnosis. In addition, ECGs are classified according 
to the Minnesota Code. (13) 
The MEANS program was first used to diagnose myocardial infarction, left 
ventricular hypertrophy and atrial fibrillation. For the diagnosis of myocardial 
infarction and left ventricular hypertrophy, the MEANS program gives a graded scale 
of certainty, being 'no', 'possible', 'probable' and 'certain'. Myocardial infarction or 
left ventricular hypeIirophy was considered present when the "MEANS program 
diagnosed the condition 'probable' or 'certain'. All ECGs were also interpreted by a 
research physician (pm) to determine the presence of atrial fibrillation. For this 
diagnosis. the judgement of the research physician served as a gold standard. 
Secondly. several EeG measurements that have been associated with an increased 
risk of cardiovascular disease, were performed. These measurements, and their 
definitions of abnormality, can be found in table 1. An overall QT interval was 
determined from the common QRS onset and T offset for all 12 leads together. To 
adjust for heart rate, Bazell's formula (QTc = QT/VRR) was used.(l4) 
The T axis was calculated from vectorcardiographic X. Y and Z leads, which can, in 
good approximation, be reconstmcted from the standard ECG leads. (15) The mean 
spatial axis is obtained by vectorially adding instantaneolls heart vectors during the T 
wave. The mean frontal axis is then taken to be the angle between the X axis and the 
projection of the mean spatial axis on the XY plane. 
71 
CHAPTER 5 
Table 1. Definitions of ECG aonormalities assessed at the screening examination. 
ECG abnormality Definition 
EeG abnormalities with potelllial therapeutic cOl/sequences 
Myocardial infarction 
Left ventricular hypertrophy 
Atrial fibrillation 
OIlier ECG abnormalities 
Presence of pathological Q waves or loss of R-wave potential in 
the precordial leads 
Combination of voltage and ST-T criteria 
Absence of P waves, irregular RR intervals 
Atrio ventricular block PR interval >200 illS 
Intra ventricular block Prolonged QRS duration 
Premature ventricular complexes Any PVC in to seconds 
ST depression ivfinllesota Code 4.1 or 4.2 
T inversion Minnesota Code 5.1 or 5.2 
Prolonged QTc Abnormal: >460 ms 
Frontal T axis deviation Abnormal: between -1800 and _150 or between 1050 and 1800 
After the ECGs had been recorded, we reviewed the computerised patient files at the 
GP's office on the presence of the diagnoses myocardial infarction, left ventricular 
hypertrophy, atrial fibrillation at any date before the screening examination. These 
conditions were considered known to the general practitioner if they were mentioned 
in the free text or problem lists of the computerised patient file. Silent infarctions were 
defined as electrocardiographically diagnosed myocardial infarction without the 
mentioning of a diagnosis of myocardial infarction in the patient file. 
Because the diagnoses of previously unrecognised myocardial infarction, left 
ventricular hypertrophy and atrial fibrillation are most likely to have clinical 
implications, they were analysed separately. The prevalences of these EeG 
abnormalities in different subgroups, notably patients with cardiovascular risk 
indicators, were assessed to determine in which subgroup electrocardiographic 
screening may be most efficacious. Furthermore, in a multiple logistic regression 
model patient characteristics, including those defining the subgroups mentioned 
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before were tested to detect independent predictors of these previously unrecognised 
ECG abnormalities. 
Results 
An ECG was recorded among 489 (87%) pal1icipants. The characteristics of the 
pmiicipants with ECG recordings me described in table 2. Nlissing EeG recordings 
were mostly due to temporary technical problems with the electrocardiographic 
equipment. Participants with an ECG recording had a higher prevalence of several 
cardiovascular risk indicators compared to pmiicipants without an ECG recording, 
although these differences were not statistically significant. 
Table 2. Characteristics of the 489 participants included in the electrocardiographic screening 
examination. 
Characteristic Mean (SD) or % 
rvlale gender (%) 48.1 
Age (years) 71.1 (S.3) 
Systolic blood pressure (mm Hg) 152.0 (20.7) 
Diastolic blood pressure (mm Hg) 81.7 (10.2) 
Total cholesterol (mmol/1) 6.1 (1.2) 
Current smoking (C/o) 17.0 
Body mass index (kg/m2) 26.2 (3.7) 
History of angina pectoris (%) 11.0 
History of myocardial infarction (%) to. I 
History of stroke or transient ischemic attack (C/o) 4.5 
History of diabetes mellitus (%) 5.1 




EeG abnormality Preyalence (%) 
Abnormalities with potential therapeutic consequences 
Myocardial infarction 9.4 
Left ventricular hypertrophy 2.9 
Atrial fibrillation 3.5 
Total 14.7 
Other EeG abnormalities 
Atria vcntricular block 12.5 
Intra ventricular block 9.4 
Premature ventricular complexes 5.3 
ST depression 5.5 
Negative T wave 9.0 
Prolonged QT c 10.2 
Deviation of the frontal Taxis 10.7 
Total 36.4 
Normal EeG 58.3 
In total, 41.7% of all subjects had an ECG recording with at least one abnormality. 
(Table 3) ECG diagnoses that are most likely to have therapeutic consequences, i.e. 
myocardial infarction, left ventricular hypertrophy and atrial fibrillation, were present 
in 14.7% of all ECG recordings and these diagnoses had not been recorded previously 
in the patient file in 8.8% of the participants. The prevalence of newly detected 
myocardial infarction, left ventricular hype1irophy and atrial fibrillation was 4.9%, 
2.9% and 1.2% respeclively. Olher EeG abnormaliIies were observed in 36.4% of all 
recordings, the most frequent being atria ventricular block (12.5%), deviation of the 
fronlal Taxis (10.7%) and prolonged QTc (10.2%). 
Of the different subgroups of patients, the yield of electrocardiographic screening 
appeared to be the highest in patients with diabetes mellitus or hypertension. If 
screening had been restricted to these subjects, 51.2% of all previously unknown ECG 
abnormalities would have been detected by screening only 30.5% of all participants. 
(Table 4) 
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Table 4, 'IlIe efficacy of selective electrocardiographic screening in temlS of the percentage of all 
patients needed to be screened and the percentage of all previously unknown abnormalities which are 
detected. 
Selection criteria Number (%) of Number (%) of % of all unknown 
patients to be patients nith ~I abnormalities that is 
screened unknown abnormality detected 
All patients 489 (100) 43 (8.8) 100 
Age >= 75 years 112 (22.9) 13(11.6) 30.2 
l'o,·fale sex 235 (48.1) 25 (10.6) 58.1 
Hypertension 134 (27.4) 19 (14.2) 44.2 
Diabetes mellitus 25 (5.1) 7 (28) 16.3 
Hypertension andlor 149 (30.5) 22 (14.8) 51.2 
diabetes mellitus 
Smoking 83 (17.0) I 1(13.3) 25.6 
Hypercholesterolemia 104 (21.3) 7 (6.7) 16.3 
History of cerebrovascular 22 (4.5) 4 (18.2) 9.3 
disease 
Diabetes mellitus (OR 4.0, 95%CI 1.5-11.2) and hypertension (OR 2.3, 95%CI l.l-
4.4) proved to be independent predictors of these previollsly unknown 
electrocardiographic abnormalities in a multivariate model. (Table 5) 
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Tab!e 5. Independent predictors of the presence of previously unknown myocardial infarctions, left 
ventricular hypertrophy or atrial fibrillation in older people. Results of multiple logistic regression 
analysis. History of hypertension, hypercholesterolaemia and diabetes mellitus was determined through 
review of patient files. 
Palient characteristic 
male sex 
age (per 5 years) 
history of hypertension 
history of hyperchoiesterolacmia 
history of diabetes mellitus 
current smoker 











In this general practice based study on the use of the ECG as a screening device in 
older people, we found ECG abnormalities in as much as 42% of participants. 
:rvloreover, clinically important ECG abnormalities with potential therapeutic 
consequences, were detected in 8.8% of all participants. These included silent 
infarction (4.9%) and previously unknown left ventricular hypertrophy (2.9%) and 
atrial fibrillation (1.2%). 
We could only find one other study that explicitly dealt with the lise of the BeG by 
general practitioners for screening purposes. In their screening survey \Vhceldon and 
colleagues diagnosed atrial fibrillation in 5.4% of participants aged 65 years and over 
and estimated that among 20% of these coumarine derivates could be prescribed. (16) 
However, the proportion of patients with atrial fibrillation which were newly detected 
by the screening was not described. Most other studies in general practice focus on the 
use of the ECG by general practitioners to create sufficient diagnostic certainty to start 
thrombolysis at home in patients with suspected acute myocardial infarction (17, 18) 
or its use as a means to select patients with suspected heart failure for 
echocardiography. (19·21) 
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Population based studies have documented the relatively high prevalence of silent 
infarctions.(7, 22, 23) However, some relied on self reported history of myocardial 
infarction and do not take the knowledge of the general practitioner about the medical 
history of the patient into account. Importantly, the prevalence of EeG abnormalities 
in our study sample did not differ from larger population based studies. 
The therapeutic consequences of detecting ECG abnormalities during screening need 
to be considered carefully. In atrial fibrillation, intervention studies demonstrated 
beyond doubt that oral anticoagulants, and to a lesser extent aspirin, reduce the risk of 
stroke. So far, no intervention studies have been performed in patients with silent 
infarctions. However, the prognosis of silent infarctions is as poor as clinically 
recognised infarctions. (7) Therefore, it seeills logical to treat silent infarctions similar 
to clinical infarctions. Tllis would include the prescription of aspirin and/or P 
blockers. Furthermore, as silent infarctions indicate arteriosclerotic target organ 
damage, preventive measures in the domain of secondary prevention, such as the 
prescription of lipid lowering drugs, may be indicated. Finally, the presence of left 
ventricular hypertrophy may serve as an argument to initiate antihypertensive 
treatment earlier. 
Although the overall prevalence of previously unrecognised myocardial infarctions, 
left ventricular hypertrophy and atrial fibrillation was not very low (8.8%), it may be 
desirable to target electrocardiographic screening at groups where a higher yield of 
screening can be expected. In our study, these abnormalities were more likely to be 
found in subjects who were older and had a history of diabetes mellitus or 
hypertension. This finding is in accordance with larger population based studies, that 
showed that infarctions are more likely to be unrecognised among those with 
hypertension and those with a higher post load glucose. (7, 22) Tn addition, atrial 
fibrillation is more frequently encountered among older subjects with diabetes 
mellitus or a history of transient ischemic attack or stroke. (24, 25) 
Although electrocardiographic measurements are not commonly used in clinical 
practice to assess an individual's risk of cardiovascular disease, they could improve 
the prediction of cardiac death. These measurements inclnde the more recently 
reported prolonged QTc interval and the deviation of the T axis, that have been 
associated with cardiac death in older people, independent of other cardiovm;cular risk 
indicators. (26, 27) 
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Our study had several limitations. \Ve used an intermediate endpoint, the prevalence 
of previously unrecognised myocardial infarction, left ventricular hypertrophy and 
atrial fibrillation, to describe the benefits of electrocardiographic screening. Effects of 
such a screening on morbidity and mortality remain to be proven. 
A second limitation concerns the generalis ability of our results. Only one practice of 
three general practitioners took parI in our study. Because these general practitioners 
were interested in cardiology and possessed an electrocardiograph, the rate of 
electrocardiographic recordings in daily practice is probably higher than in other 
practices. This would lead to a relatively low prevalence of previously unrecognised 
EeG abnormalities. Generalisability is further hampered by the fact ollr EeG study 
was part of a repeated health check in a cohort of older people. Because those who did 
not take part in the first health check were not invited at the repeated check tlve years 
later, which included the electrocardiography, the study group comprised only of 
60.4% of all patients of that age group registered in the practice. Among the patients 
who were invited however, we were able to achieve a response rate of as much as 
80%, which is comparable to the rates generally reached by screening activities in 
general practice. 
In conclusion, the EeG offers the general practitioner a possibility to screen patients 
on subclinical cardiovascular disease and initiate preventive treatment. \Vhen tIus 
strategy is applied to all elderly, potentially therapeutic consequences will follow in 
approximately 10% of all participants. Targeting screening to those with diabetes or 
hypel1ension can further improve cost effectiveness of electrocardiographic screening. 
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Effectiveness of repeated screens for heating loss in the elderly 
CHAPTER 6 
Introduction 
Hearing loss is amongst the most frequent impaimlents of the elderly. (1) Untreated it 
may lead to social isolation and it may interfere with the wish of many elderly to live 
independently. (2, 3) Correlations between hearing impairment, depression and 
cognitive impairment have been reported. (4-9) The regular use of a hearing aid can 
improve communicative and cognitive functioning and increase quality of life. (10) 
Hearing impairment, however, is often not recognised, even not in patients who visit 
their physician regniariy. (1\) 
A systematic assessment of hearing loss by audiometric screening, whispered voice 
test or by questionnaires will identify some patients who may benefit from the use of a 
hearing aid. In addition, the hearing test itself may provide a reason for the physician 
to discllss the possibilities of hearing rehabilitation with the patient. However, studies 
show that the effect of a single screen with a pure tone audiometer, as measured by 
the provision of hearing aids, is not optimal. In 19% to 48% of the hearing impaired 
subjects that could benefit from a hearing aid, such a device was actually prescribed. 
(12-14) Repeated hearing assessments may help to remind patients and physicians of 
the continued need of assessing the possible benefits of hearing aids. Furthermore, 
repeated screenings will allow the detection of new cases and the identification of 
patients with progressive hearing loss. (15) 
\Ve addressed this issue by comparing the number of hearing aid provisions in 
patients with a hearing loss after the first and a repeated hearing screen in a cohort of 
elderly aged 60 years and over. In addition, our study provides information on the 
development of hearing impairment in the elderly over a period of five years. 
Methods 
The study was carried out in a group practice with three general practitioners in 
Krimpen aid JJssel, a residential town near Rotterdam, the Netherlands. In 1991, all 
men and women of 60 years and over who were registered in this practice and who 
did not suffer from severe physical or mental diseases according to their general 
practitioner were invited to participate in a screening survey. The screening survey 
was repeated in 1996. Hearing assessments were part of these two surveys, which 
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further focussed on the detection and management of risk indicators for 
cardiovascular disease among elderly. 
The results of the first hearing screen of the 660 participants in 1991 were published 
elsewhere.( 16) In 1996, 69 of the participants of the first screening examination had 
died, 35 had moved to another area or to another general practitioner and 3 were lost 
from the files for some unknown reason. Another 9 persons had to be excluded from 
further study because of a terminal disease (n=5), dementia (n=3) or for not being able 
to come to the general practitioner's office (11=1). The resulting 544 patients were 
invited by letter to visit the surgery for a combined cardiovascular health check and 
hearing screen. If they did not respond, the written invitation to participate was 
repeated once near the end of the study. In total 444 (81.6%) persons participated in 
the study. A hearing assessment was not performed in 39 patients (8.1%) because of 
one of the following reasons: ear wax that could not be removed (n=2), wearing of a 
hearing aid (n=18) or logistic reasons (11=7) e.g. the temporary unavailability of the 
audiometer. Twelve persons did not participate for unknown reasons. Thus, a hearing 
screen took place in 405 persons. 
The hearing screen was performed by a research physician (pm). It consisted of a 
questionnaire including questions about hearing complaints as pmt of a larger 
interview about the cardiovascular health status. Next, the ears were examined for 
wax or abnormality. \Vax was removed and abnormalities registered and, if needed, 
treated. Finally, audiometry was carried Ollt in a quiet, but not acoustically isolated~ 
consulting room using the Bosch ST20 pure tone screening audiometer. Both ears 
were tested at the frequencies 1, 2 and 4 kHz. The average loss was calculated and 
categorised using the criteria developed by Herbst et al. (4) The result of the hearing 
screen was immediately discussed with the participants and was also send by mail to 
the patients a few weeks after the hearing screen. Mild hearing impairment was 
defined as an average loss of 35-44 dB, moderate impairment as an average loss of 
45-69 dB and severe impairment as an average loss of 70 dB or more. When the 
hearing loss in one or both ears was more than 40 dB, patients were recommended to 
contact their general practitioner to discuss the possible lise of a hearing aid. In the 
Netherlands, general practitioners are responsible for referring patients to audiologic 
centres or specialists in otolaryngology. The cut-off point of hearing loss of 40 dB in 
one or both ears was chosen after discussion with the general practitioners in the 
research practice and is slightly higher then the cut-off point of 35dB in the best ear, 
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that is used by the health authorities in the Netherlands to reimburse the costs of 
hearing aids. 
The computerised patient records of the participants whose hearing was found to be 
impaired at the first hearing screen in 1991 were reviewed to obtain a complete follow 
up on the possible prescription and usc of a hearing aid between 1991 and 1996. The 
computerised patient records are used by the participating general practitioners to 
record every consultation. Analogously, the number of hearing aids prescribed before 
I January 1998 were determined in those whose hearing was found to be impaired at 
the second hearing screen in 1996. 
\Ve lIsed the Chi-Square test to examine whether discllssion of patients with the 
general practitioners about hearing complaints. referral to a specialist in 
otolaryngology and provision of hearing aids differed between patients with and 
without relevant characteristics. Differences in number of patients with the presence 
or absence of hearing loss or hearing complaints in 1991 and 1996 among patients 
who attended both hearing screens were tested by applying Mc Nemar's test. We 
analysed the change in the average hearing loss at the frequencies 1,2, and 4 kHz for 
each patient between the first and the second audiometric screen by using the general 
linear mixed model of the SAS package. A logarithmic transformation was performed 
to obtain a normal distribution of the mean hearing loss values. 
Results 
Effectiveness first screen 
In the five years after the first hearing screen and before the second screen, a hearing 
aid was prescribed in only a minority (16.9%) of the 177 participants in whom an 
average hearing Joss of 40 dB or more on the frequencies 1,2 and 4 kHz for the left or 
right ear had been found and whom thus had an indication for a hearing aid. (Table 1) 
In almost all of these patients, the hearing aid was prescribed within one year after the 
audiometric screen. In only 50 (28.2 %) of participants with hearing impairment in 
1991, a notice was found in the patient's file referring to a discussion of this problem 
between patient and general practitioner. Forty-three (86%) of those patients were 
referred to an otolaryngololist and fifty-four percent of these received a hearing aid. 
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Table 1. Effect of the first screen categorised in discussion of the hearing loss with the general 
practitioner (GP), number of hearing aid prescriptions and referrals to a specialist in otolaryngology 
among those with a hearing impairment (n=247) in the five years following the first hearing screen. An 
asterisks (*) denotes a statistically significant difference (p<O.05) between hearing impaired patients 
with the characteristic compared to hearing impaired patients without the characteristic. 
To(al Discussed with Referral Hearing aid 
GP 
number % number % number % 
Hearing impairment 
All hearing impaired 247 60 24.3 53 21.5 30 12.1 
Lightly impaired 166 33* 19.9* 28* \6.3* 15* 9.0* 
Ivloderately impaired 77 25* 32.5* 23* 29.9* 14 18.2 
Severely impaired 4 2 50.0 2 50.0 25.0 
Indication hearing aid 177 50' 28.2* 43* 24.3* 27' 16.9* 
Hearing impairment and: 
r-.Jale sex 137 37 27.2 22 19.8 18 13.2 
Age 75 years and over 65 17 26.2 12 18.5 7 10.8 
Two sided hearing loss 155 39 25.2 36 23.2 22 14.2 
Complaints of hearing loss 159 48* 30.2* 43* 27.0* 26* 16.4* 
Progression of hearing loss be/ween the hvo screens 
In 1996, 80.2% of the eligible patients participated in the repeated hearing screen. 
Those participants were younger and had a lower prevalence of hearing impairment at 
the first screen in 1991 as compared to those who did not attend or had died or moved 
between the two screenings surveys (Table 2). Of the 23 subjects prescribed a hearing 
aid after the first assessment in 1991and participating in the 1996 study, five had 
stopped wearing the aid. 
Table 2. Population characteristics (%), determined at the first hearing screen in 1991, of the subjects 
attending a repeat screen after 5 years in 1 996(n=405), of non~attenders in 1996(n=100), of those who 
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were lost from the follow up (Le. had dicd or moved, n=107) and of those who were excluded (n=48). 
An asterisk (*) denotes a statistically significant difference (p<0.05) with attenders. 
Characteristic Attenders Non aHcnders Died or movcd Excluded 
n=405 n=100 n=107 n=48 
Age (years) 
60-69 78.7 62.0* 52.3* 66.7 
70-79 18.0 32.0* 24.3 31.3* 
>=80 3.2 6.0 23.4* 2.1 
Hearing impairment 
Light 24.0 29.0 17.8 45.8* 
1'lodcrate 5_7 13.0* 27.1* 25.0* 
Severe 0.7 0.0 0.0 2.1 
Hearing aid prescribcd 1.2 4.0 2.8 37.5* 
l .... lale sex 48.4 47.0 48.6 52.1 
Collective health insurance 37.0 52.0* 42.1 41.7 
The mean hearing loss at the first audiometric examination was 25.58 dB for the right 
and 25.3 dB for the left ear. On average. the hearing loss increased between the first 
and Ihe second measurement by 1.9 dB (95%CI 1.2-2.8) and 2.1 dB (95%CI 1.3-2.8) 
dB for the right and left ear respectively. The prevalence of moderate hearing loss 
increased in the five years between the I\vo measurements from 5.7% to 13.1% (Table 
3). In contrast, the number of people with a light hearing loss had decreased. Of the 82 
subjects whose hearing loss was above the Cllt off value for the prescription of a 
hearing aid in 1991. hearing loss had decreased below that value in 19 (23%) patienls. 
Table 3. Prevalence of hearing complaints and hearing loss for those attending the first and second 
hearing screen (n=405). An asterisk (*) denotes a significant difference of the second screen with the 
first screen. (McNemar) TIle mean age of attenders was 68.4 years in 1991 and 71.4 years in 1996. 
Degree of hearing impairment First hearing screen (1991) Second hearing scrcen (1996) 
Hearing complaints 
Tinnitis 17 41* 
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Difficulty with hcaring 101 69 * 
Both 15 40* 
Hearing loss 
Light 97 75* 
Moderate 23 54* 
Severe 3 8 
Effectiveness of the repeated screen 
Hearing aid prescription after the second screen was about half as frequent as after the 
first screen (Table 4), A hearing aid was prescribed in 10 (2.5%) participants or in 
7.3% of those with a hearing loss of over 40 dB in the right or left ear. Most of the 
participants who had a hearing aid prescribed had a moderate hearing loss. None of 
those with a severe hearing loss (11=8) discussed this problem with their general 
practitioner or had a hearing aid prescribed. However, tltis hearing loss was onc~sided 
in all these patients. 
Factors ilt{luendng prescription of hearing aids 
After both screens, more hearing aids where prescribed if the severity of the hearing 
loss was more severe and if complaints where present. Even among these subjects, 
however, the incidence of hearing aid prescription after the screens was never higher 
than 18.2%. Gender, age and whether the hearing loss ,vas two sided or not did not 
clearly influence prescription rate of hearing aids (Table 4). 
Table 4. Effect of the second screen categorised in discussion of the hearing loss with the GP, referrals 
to a specialist in otolaryngology and number of hearing aid prescriptions and among those with a 
hearing loss (n=137) in at least 112 year after the second hearing screen. An asterisks {*} denotes a 
statistically significant difference (p<O.05) between hearing impaired patients with the characteristic 
compared to hearing impaired patients without the characteristic. Light, moderate and severc hearing 
impairment and indication hearing aid corrcsponds to an average hearing loss at I, 2 and 4 kHz of 35-
44,45-69,70 or more, and 40 or more, respectively, in the right or left ear. 
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Total Disclissed with Referl'al Hearing aid 
GP 
number % number % number % 
Hearing impairment 
All hearing impaired 137 23 16.8 19 13.9 10 7.3 
Lightly impaired 75 3' 4.0* I' 1.3* I' 1.3' 
rvfoderately impaired 54 20' 37.0* 18* 33.3* 9' 16.7* 
Severely impaired 8 0 0.0 0 0.0 0 0.0 
Indication hearing aid 101 22* 21.8* 19* 18.8* 10 9.9 
Hearing impairment and: 
~'lalc sex 80 15 18.8 13 16.3 6 7.5 
Age 75 years and over 50 9 18.0 7 14.0 5 10.0 
Two sided hearing loss 90 18 20.0 14 15.6 8 8.9 
Complaints of hearing loss 94 21* 22.6* 18* 19.4* 10* 10.8* 
Discussion 
Hearing aid provision in this sample of the elderly people Hving independently was 
disappointingly low after a single hearing screen. We hypothesised that a second 
screen would increase awareness and promote rehabilitation. The added value of the 
repeated screen was limited to a hearing-aid provision in only an additional 7.4% of 
the participants with hearing loss. 
The number of patients with hearing loss that had a hearing aid prescribed after a 
single audiometric screening (12.5%) is lower than that reported in the literature. 
Other studies of hearing screens in general practice show a hearing aid prescription 
rate of \9%, 28% and 49% respectively among elderly \Vilh hearing loss. (4, 13, 14) 
Since these surveys specifically aimed at detecting hearing problems, they might have 
attracted more motivated elderly than those who attended our health check, in which 
the audiogram comprised only a small part of the measurements. Furthermore, these 
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higher rates may be attributable to a more intensified follow-up of the hearing-
impaired participants. This suggests that general practitioners should be prepared to 
invest more time and effort in an adequate foHow up of identified people with a 
hearing loss in case audiometric screens are performed. 
To aliI' knowledge, the effect of a repeated audiometric screens on hearing aid 
prescription has not been reported before. The response rate to participate in the 
repeated screen was high (80.2%). However, the younger age and the better hearing in 
responders compared to non-attenders, may result in a smaller detection rate of 
hearing-impaired patients. Because sllccessful acceptance of a hearing aid is on 
average better in younger than in older subjects, and because the time period during 
which they may profit from the aid is longer, these new cases are, however, 
potentially more important. (17) The sholier follow up time after the repeated (6 
months or less) compared to the first (5 years or less) audiometric screen could partly 
explain the lower prescription rate. However, after the first screen most hearing aids 
were prescribed within a short time span. 
Audiometric examinations have certain limitations. They are performed in a quiet 
room, while hearing problems can be most apparent in conversations in noisy 
environments. Furthermore, they measure only loss and not the way the patient deals 
with this loss in daily life. Therefore, one could screen on hearing handicap instead of 
hearing loss by using a questionnaire. It has been shown that help seeking behaviour 
is higher when the perceived handicap is higher. (18, 19) Thus, screening by means of 
a combination of a questionnaire and audiometry and subsequently offering a hearing 
aid is likely to be more efficient than audiometric screening alone. (20) In our study, 
the presence of complaints was associated with a higher hearing aid use after the 
screening. 
Our data provide information on the development of hearing impairment in the 
elderly. However, these data should be interpreted with caution. Firstly, regression to 
the mean will have diluted observed progression of hearing impairment and 
interobserver variation will have resulted in reduction of the precision of our 
estimates. Secondly, the hearing screen was not repealed for those who had been 
prescribed a hearing aid in the five years between the two screens and were still using 
the aid (n;:;18). Thirdly. those with better hearing were more prone to participate in the 
repeated hearing screen. These factors may explain why we found only a moderate 
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progression of hearing loss. Nevertheless, hearing loss was progressive in our study, 
which in itself is an argument in favour of repeated screenings. 
\Ve conclude that hearing impairment is frequent and progressive but that it leads to 
referral to an otolaryngolist and the prescription of a hearing aid in only a minority of 
the cases. Repeated audiometric screens are of limited value when the aim is to 
increase the use of hearing aids. Standardised follow up procedures of those with 
hearing loss are cmcial, while attention to the self perceived handicap may further 
increase the rate of hearing aid provisions. If these conditions are not met, efforts to 
screen on hearing loss will be fmitless and can best be avoided in general practice. 
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Preventive health care is promising. Nevertheless, not all preventive programmes are 
desirable. In deciding which programme should be implemented, experts often 
disagree. These controversies were categorised by Schaapveld et al. for a number of 
preventive initiatives and include efficacy, effectiveness, ethics, competing causes of 
morbidity and execution of the programme. These controversies can be found in more 
detail in table I. (I) 
Table 1. Controversies frequently associated with preventive programmes, as categorised by 
Schaapvcld ct al.(1) 




Description of controversy 
Docs the intervention offered by preventive programs lead to a substantial 
improvement in health in randomiscd trials? 
Docs the intervention offered by preventive programs lead to a substantial 
improvement in health in every day patient care? 
To what extent are the benefits of a screening programme outweighed by 
unwanted effects which harm the health of its participants? 
Competing causes of To what extent arc the benefits of the screening programme outweighed by 
morbidity and mortality a shift to other prevalent causes of morbidity and mortality? 
Execution How must the screening programme be carried out within the health care 
system? 
This thesis demonstrates the promises of some forms of preventive health care in the 
elderly, notably screening for cardiovascular risk indicators, the assessment of 
cardiovascular medication used. and screening for hearing loss. However. the 
introduction of this research progranmle as a screening programme in general practice 
would undoubtedly lead to controversies. \Ve discuss these controversies. as 
mentioned in table I, with reference to our research findings. 
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Efficacy 
The efficacy of screening programmes depends on the proportion of patients screened 
positive (e.g. in whom an elevated blood pressure was found) and the efficacy of the 
interventions. 
At the single and a repeated cardiovascular health check after five years, we found at 
least one risk indicator not recorded in the patient file in 25.1 % and 14.5% of the 
participants, respectively. In addition, 8.8% of the participants had ECG abnormalities 
with potential therapeutic consequences. Furthermore, the cardiovascular medication 
review identified ample possibilities to improve prescription. Finally, audiometric 
screening detected hearing loss in 37.4% and 33.8% of patients at the first and 
repeated screening respectively. These proP0l1iolls compare favourably with detection 
rates of other screening programmes, such as screening for cervical cancer. 
Evidence on efficacy of interventions in the elderly is scarce. Older adults, notably 
those above 75 years of age, are often excluded from randomised trials. In major 
medical journals, one third of all published trials exclude elderly people without 
justification. (2) In 73% of trials that focussed Oil the treatment of acute myocardial 
infarction in 1980-1991, a maximum age was defined. The average age of participants 
of these trials was 56.8 years while most people experience their first myocardial 
infarction later in life. (3) 
Recent hypertension trials did include older people up to eighty years and clearly 
demonstrated the benefit of antihypertensive treatment. (4-7) IvIost of these tfials were 
performed decades after such benefit was demonstrated in middle aged adults. In the 
meantime, practitioners have been left with little scientific data on the risk-benefit 
ratio of treating older patients for hypertension. In retrospect, this lack of conclusive 
evidence will have contributed to undertreatment of hypertension and isolated systolic 
hypertension. 
The efficacy of lowering cholesterol levels in older subjects has becn debated. (8-12) 
Recently, trials that focussed on secondary prevention clearly demonstrated a risk 
reduction in the occurrence of major cardiovascular events in patients aged 60 and 
over. (13, 14) On the other hand, the benefits of lipid lowcring in elderly without 
evidence of cardiovascular disease are only modest. (15) Thus, measuring cholesterol 
levels in older patients should primarily be targeted at those with manifest 
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cardiovascular disease. This illustrates that evidence on the efficacy of interventions 
can change substantially over time. Periodic health checks can serve as a means to 
adjust therapy to the current standards. 
Effectiveness 
Controversies about the effectiveness arise when experts do not agree on the extent to 
which the theoretical benefits of an efficacious screening programme translate into 
benefits in clinical practice. The effectiveness particularly depends on the response 
rates when screening programmes are introduced, on the extent to which positive 
screening results are followed by interventions and finally on the benefits of the 
interventions when they are offered to 'real life' patients instead of participants of 
clinical trials. 
The response rates strongly depend on the way the screening programme is executed. 
Invitation and execution of the program by the general practitioner and a repeated 
invitation to non-responders all improve response rates. In this way, we were able to 
reach response rates of 80%. These are comparable to the high response rate achieved 
by the national screening program on cervical cancer, also executed by general 
practitioners. 
Knowledge of the presence of a risk indicator by the treating physician or the patient 
is not enough, as not all patients will subsequently receive an intervention. After the 
first cardiovascular health check in 1991, only 6/25 patients with previollsly unknown 
hypertension received antihypertensive dmgs. The literature confirms that, although 
efficacious, antihypertensive treatment is often not initiated in patients with 
hypertension. Factors that determine whether drug treatment is initiated include blood 
pressure level and Ihe palienl's age. (16-18) The Ihreshold blood pressure used by 
general practitioners to prescribe antihypel1ensive treatment is usually higher than the 
level advised in the guidelines. In a survey performed in 1993,51% of the general 
practitioners in the UK, contrary to existing guidelines, did not treat isolated systolic 
hyperlension al all. (16) 
Another example of the way in which lack of interventions after screening hampers 
the effectiveness of a screening programme is the issuing of hearing aids after 
screening on hearing loss. Although one trial and several observational studies 
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unequivocally showed the efficacy of these devices, few elderly will usc a hearing aid 
after audiometric ally demonstrated hearing loss. (19,20) 
When interventions are started after a positive screening result, the benefits of these 
interventions are often less than expected on the basis of the findings in randomised 
controlled trials. This can be explained partially by the highly selective process by 
which participants of clinical trials are recruited and by the efforts to motivate patients 
during the follow up period. The lack of comorbidities and comedications make trial 
participants quite distinct from patients seen in evelY day practice. (21, 22) In 
addition, non compliance and poor patient management playa role. 
For example, when treatment with anti hypertensive drugs is stm1ed, target blood 
pressure levels are often not reached. Berlowitz et al showed that among older men 
with more than six hypertension related visits per year, 40 percent had a blood 
pressure above 160/90. This can be explained by a lack of compliance or, as the 
authors suggest, by inadequate patient management. (23) 
Ethics 
'Primum non nocere' is an ethical principle which is used to guide the practice of 
medicine. In preventive medicine, this principle is even more crucial since we are 
actively offering medical care instead of responding to needs of care. The potentially 
harmful effects of screening include taking away healthy time from people, decreased 
quality of life, the offering of false assurance and increased medicalisation of old age. 
(24,25) 
Screening of poor quality, i.e. which does not fulfil the criteria of \Vilson (Chapter I), 
may cause more harm than benefits. In addition to Wilson's criteria, respect for the 
patients autonomy and a focus on the patient's and society's well-being can be 
mentioned as criteria for an ethically acceptable screening programme. Patients must 
have the freedom to decide whether or not to pm1icipate in the programme or to 
accept the intervention. The well-being of the patient and the society at large should 
be kept in .mind all times to ensure that screening programmes do morc good than 
harm. 
Quantitative evidence of harmful effects of screening on cardiovascular risk indicators 
which cast doubt on the ethics of screening efforts was first reported by Haynes et ai, 
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who found an increased absenteeism from work among those who were labelJed 
hypertensive at a screening examination in the workplace. (26) In a general practice 
setting. Stoate demonstrated that compared to controls, patients' own assessment of 
psychological distress was significantly increased three months after a cardiovascular 
screening programme. (27) However, these results were not confirmed by the 
investigators of the British Family Hcm1 Study, a randomised clinical trial aimed at 
demonstrating the effects of nurse lead intervention on the prevalence of 
cardiovascular risk indicators. Indeed, they found that the intervention group rated 
their health higher than the control group. As the authors state, tltis might be partly 
explained by the patient centred approach adopted by the nurses and by changes in the 
social and cultural acceptance of screening. (28) In a study in the Netherlands, among 
those patients at high risk for cardiovascular disease the perception of the general 
health status did not decrease after one year of intervention. (29) Thus, cardiovascular 
screening in the middle aged docs not seem to do much harm. It is unlikely that 
cardiovascular screening will have more harmful effects in older adults than in middle 
aged adults. 
The effects of screening for hearing loss, either beneficial or harmful, have not been 
evaluated in older people. The prevalence of hearing loss is high but only a minority 
of patients does accept a hearing aid. This means that screening often leads to a 
diagnosis only and treatment will not be initiated in a substantial number of 
participants. It can be questioned whether this is ethically acceptable. The same holds 
for electrocardiographic screening. In .our study we detected electrocardiographic 
abnormalities that would not have led to differences in treatment in 36% of all 
patients. 
Competing causes of morbidity and mortality 
The pessimist's argument, which is often heard when it is comes to preventive care in 
older age, is that it is simply started too late. What can be gained by prevention of one 
disease, ego cardiovascular disease at older age, Illay be lost as a consequence of a 
shift to other frequent causes of morbidity and mortality, such as cancer. It was 
calculated that if all cardiovascular disease could be eliminated, the life expectancy of 
a 65 year old male would increase by 3.5 years, of which 2.7 years would be spend 
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with disabilities. (30) These models raise the question whether healthy life expectancy 
increases substantially, when we are offering preventive care to older adults. 
Improvement in prevention and treatment may accomplish a trade-off between 
mortality and morbidity. In the Netherlands, for example, the decreased case fatality 
rate after myocardial infarction increased the prevalence of more chronic forms of 
cardiovascular diseases, notably heart failure. (31, 32) A case fatality decline has also 
been observed in acute stroke, the survivors being at high risk to develop a major 
stroke at older ages. (33) Nevertheless, in the Netherlands the recent increase in life 
expectancy has been associated with a prop0l1ionai increase in healthy life 
expectancy. (34) 
In contrast with prevention for cardiovascular disem;e, which aims at reduction of 
morbidity and m0l1ality, competing causes of mortality and morbidity are not an issue 
for preventive measures directed at functional limitations, such as hearing loss. This 
makes increasing functional status a valuable goal for prevention in the oldest old 
where competing causes of morbidity and mortality are highly incident. (30, 35) 
Execution 
Although some forms of preventive care are promising, general practice may not be 
adequately equipped to execute these programmes. This is illustrated by the various 
ways in which the compulsory health checks for older adults are carried out in the 
UK. (36, 37) On the other hand, simple preventive programs, such as influenza 
vaccination, have been implemented successfully in general practice. (38) Apart from 
motivational issues, practical barriers to the implementation of preventive care can be 
identified. (39) 
Firstly, it may not be clear which strategy should be preferred to identify those with a 
high risk of cardiovascular disease. Since the strategy determines the workload of the 
screening, the pro's and COil'S of each strategy should be carefully considered. A 
general practitioner could offer a screening test (e.g. measurement of blood pressure) 
while being consulted by a patient for another reason. This case finding strategy may 
be appropriate when screening the elderly because this age group frequently consults 
a general practitioner and those who do not are relatively healthy. However, not all 
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consultations offer the possibility for case finding and thus it may take a long time 
before the entire population at risk is screened. 
In addition, care must be taken to perform case finding systematically. Not 
surprisingly, we identified many hypertensive subjects at our health checks who were 
not detected previously by normal care case finding. 
Actively inviting subjects by mail or telephone to participate in a preventive 
programme is the alternative. More patients can be reached systematically in a short 
time span. However, this approach contrasts with the roles practitioners and patients 
have adopted over time. Furthermore, it requires more effort from practices and 
patients. Probably a combination of the two strategies, case finding followed by 
invitations for those who have not been screened opportunistically after a fixed period 
of time, combines the strong points of each strategy. 
Secondly, it should be decided at which interval the screening examinations have to 
be performed. We repeated our screening examination after five years in the same 
group of patients and our major finding was that 9.2% of the participants had isolated 
systolic hypertension which had not been recorded previously in the patient file. Thus, 
after a five year interval repeated screening on isolated systolic hypertension will 
detect sufficient numbers of new cases or cases with insufficient follow-up after the 
first screening. Repetition of the screening on hearing loss after five years revealed 
comparable proportions of patients ,vith hearing loss after the first and the repeated 
screening, but a reduced number of hearing aid prescriptions after the repeated 
screening. Thus, repetition of screening on hearing loss is not a preferable strategy to 
diminish the problems of hearing loss. Instead, the follow-up after screening should 
be improved to ensure that more hearing aids are issued among those in whom a 
hearing loss is detected. 
Thirdly, the demand the introduction of a preventive programme in a general practice 
places the organisation of the practice needs to be considered. A survey in the 
Netherlands in 1991 showed that more than half of the practices were not equipped to 
perform preventive services. (39) Improvement of the practice organisation may prove 
to be the most important challenge facing the implementation of preventive care. Aids 
to improve the practice organisation include the use of the expertise of practice 
nurses, practice assistance and facilitators, and optimal use of computers. 
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Practice nurses have not been introduced in the Netherlands on a large scale. Several 
experiments show that the introduction of nurses may improve patient care mainly 
because health care is offered according to guidelines more systematically. (40) 
Preventive care, which requires such a systematic approach, may benefit from the 
introduction of these health professionals. In the United Kingdom, nurses already 
execute many preventive tasks. Practice assistance in the Netherlands have long been 
involved in administrative duties only, but could. if appropriately cducated, playa 
more active part in preventive care. 
Facilitators are health care professionals who assist general practitioners and practice 
assistants with the implementation of preventive care by using a structured approach, 
including practice visits and group education. Facilitators have shown to be able to 
improve practice organisation in the UK. In the Netherlands, the may have 
comparable beneficial effects (41, 42) 
Finally. computers are mandatory to identify patients for case finding or selective 
screening. FtII1hermore, they may guide treatment decisions, including those on 
preventive therapy, and may educate patients about their cardiovascular risk. (43) 
Although investments to improve practice organisation are costly, it should be noted 
that they will also serve to adapt general practice to future rcquirements. such as 
providing care for the ageing population, consultations for specific groups of patients 




This chapter discussed the implications of offering a cardiovascular screening 
program and a screening program on hearing loss to older adults. Both screening 
programmes offer the OP ample new information on the health of their older paticnts. 
Screening on hypertension Of isolated systolic hypertension by a combination of case 
finding and screening by invitation and a regular revic\v of the cardiovascular 
medication used by older adults should be introduced in general practice. To assure 
systematic execution of these programmes and adequate follow up, improvement of 
practice organisation is mandatory. 
Until now, screening on hearing loss fails to live up to its promises. Although many 
patients with hearing loss could be identified, only a minority accepted an 
intervention, the issuing of a hearing aid. Research should firstly be focused on the 
identification of barriers to accept an hearing aid and thus offer ways to better educate 
patients and their doctors about the benefits of these devices. 
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During the last decades, Western countries have witnessed a growth of their older 
population. Nowadays, people live longer than ever before. In the Netherlands, life 
expectancy at birth in 1994 was 2.1 year higher for men and 1.1 year higher for 
women compared to 1980 and is predicted to have risen by an additional 2.5 years for 
men and I year for women in 2015. However, not all older adults spend those extra 
years in good health. Of their 74.3 years, which is the life expectancy at birth for 
males in the Netherlands, on average only 60.1 years will be spend in good health. 
ln view of this seemingly inevitable burden of disease, cff0l1s to postpone disease and 
preserve good health in the elderly are becoming morc impm1ant. Prevention at older 
age focuses on offering interventions that reduce premature death or prevent or 
postpone the occurrence of disease or improves functional status. For example. the 
treatment of hypertension is directed at the first two endpoints whereas the 
prescription of a hearing aid is expected to improve functional status. Generally, the 
older a person becomes the more the aim of prevention shifts toward improvement of 
functional status. 
Prevention is considered a task of general practitioners but it is debated if general 
practitioners should offer preventive services to older patients. 
In chapter I we discussed the promises and unresolved areas of preventive care for the 
elderly in general practice, with reference to the prevention of cardiovascular disease, 
which is highly prevalent and is the main cause of death among older adults, and the 
prevention of the consequences of hearing loss, which is a major cause of functional 
limitation at older age. 
Screening on cardiovascular risk indicators and hearing loss by general practitioners 
seems promising as it meets most of Wilson's criteria of screenings activities. 
SUMMARY 
Unfortunately, however, doubt remains whether screening can be performed 
continually in general practice, whether the facilities exist in general practice to assess 
and follow-up those screened and whether screening is economically justifiable. We 
conclude that more research is needed to solve two additional areas of uncertainty; the 
applicability of the evidence on the efficacy of interventions in older adults in primary 
care and the feasibility of screening programmes in every day practice. 
In chapter 2 we studied the feasibility and the diagnostic or therapeutic consequences 
of a single cardiovascular health check in adults aged 60 and over. 
In 1991, 1002 persons aged 60 years and over, enlisted in one general practice were 
invited. Of the 805 subjects who responded (response rate 80%) the cardiovascular 
risk profile was determined by a research physician. The proportion of newly detected 
cardiovascular risk indicators \vas the main outcome measure. 
In 25.1 % of the participants one or more cardiovascular risk indicators were found 
that were previously unknown to the GP, including 38 (4.7%) cases of hypertension, 
82 (10%) cases of isolated systolic hypertension, II (1.4%) cases of diabetes mellitus 
and 63 (7.8%) cases of hypereholesterolaemia. On the basis of these findings, the GP 
initiated therapeutic interventions in almost all subjects with newly detected diabetes. 
However, reports of newly detected hypertension or high cholesterol levels were 
usually not followed by an intervention. 
Thus, although a single cardiovascular health check in the elderly can detect a 
considerable number of risk indicators, its effectiveness may be limited by the lack of 
interventions. More efforts are needed to ensure that the beneficial effects of these 
interventions are not limited to participants in clinical trials but can be extended to 
patients in general practice. 
Since cardiovascular risk changes over time, a repeated cardiovascular health check 
may be of value. In chapter 3 we describe our finding of a repeated cardiovascular 
health check performed five years after a first health check, within the same cohort. A 
total of 509 elderly men and women, registered at the study practice and aged 60 
years and over at the first health check participated (response rate 80%). \Ve observed 
newly detected risk indicators in 14.5% of all participants; these risk indicators being 
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hypertension (2.2%), isolated systolic hypertension (9.2%), diabetes mellitus (0.8%) 
and hypercholesterolemia (3.5%). However, about 40% of these risk indicators were 
already observed at the tirst health check but were not adequately followed-up. 
We conc1uded that a repeated cardiovascular health check in the elderly may be of 
value to inform the general practitioner about previollsly unknown risk indicators, 
notably isolated systolic hypertension. However, this benefit would be significantly 
reduced if all risk indicators found at the first health check were adequately followed-
up. Furthermore, the same benefit at lower cost is likely to be obtained by focusing 
preventive etIorts on improving case finding for isolated systolic hypertension. 
In addition, a cardiovascular health check can be of value to review the use of 
cardiovascular medication or to be more informed about the cardiovascular risk of 
participants by means of electrocardiographic findings. Among participants of the 
repeated cardiovascular health check, we performed two studies to demonstrate the 
effects of the health check on these endpoints. 
Inappropriate prescription or improper use of cardiovascular medication can cause 
undesired effects, particularly in older people. To prevent such effects, it has been 
suggested to regularly review the medication llsed by older persons. In the 
Netherlands however, where routine monitoring of prescribed medication is high, the 
additional value of medication reviews may be limited. 
In chapter 4 we addressed this issue by reporting the results of a quantitative 
assessment of the benefits of a medication review. A total of 560 men and women, 
aged 64 years and over, were illten'iewed about their medication use and current 
medications, dosages, reasons for use and the prescribing doctors were registered. 
Among these subjects, 209 (37.3%) users of cardiovascular medication were 
identified. After the interview, the information given by the participants who used 
cardiovascular medication was compared with the information available in the general 
practitioner's (GP's) computerised patient file. 
The GPs knew of 92% of the prescribed cardiovascular drugs used by their older 
patients. Dosages below the minimum effective dose were present in 19% and 
interactions in 18% of all prescriptions for cardiovascular dmgs. Generally. there was 
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a low adherence to prescription guidelines for hypertension, angina pectoris and heart 
failure. In many cases, patients were unaware of the indication for their dmg 
treatment. 
We concluded that medication reviews are a valuable tool to ensllre safe and effective 
use of cardiovascular medication by older people, even when standards of medication 
monitoring are relatively high, such as in the Netherlands. 
Electrocardiograhpy is frequently used in clinical practice for the diagnosis and 
management of heart disease. In addition, a GP may consider to llse the ECG in 
asymptomatic patients as a tool to guide cardiovascular risk stratification. 
In chapter 5 we report the results of an assessment of the value of 
electrocardiographic screening of older people in general practice. BeG recordings 
were obtained from 489 patients, aged 64 years and over. The BeG recordings were 
interpreted by Ihe Modular ECG Analysis System (MEANS), a validated ECG 
interpretation programme. 
Among 41.7% of our participants an EeG abnormality was found. The ECG detected 
one of the following previollsly unknown EeG abnormalities that may have 
therapeutic consequences in 8.8% of the participants; myocardial infarctions (4.9%), 
left venlricular hypertrophy (2.9%) and atrial fibrillation (1.2%). Diabetes (OR 4.0) 
and hypertension (OR 2.2) were independent predictors of the presence of these newly 
detected abnormalities. The most frequent other EeG abnormalities included 
atrioventricular block (12.5%), deviation of the frontal Taxis (10.7%), and prolonged 
QTc inlerval (10.2%). 
In conclusion, electrocardiographic screening provides the GP with additional 
information about the presence of silent infarction, left ventricular hypertrophy and 
atrial fibrillation in approximately 10% of the screened patients. Targeting screening 
at those with diabetes or hypertension will further improve the cost effectiveness of 
electrocardiographic screening in older people. 
In chapter 6 we change foclls from cardiovascular disease, which is the major cause of 
death in the Netherlands, to a major cause of functional limitation, hearing loss. 
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Hearing loss is amongst the most frequent impairments of the elderly. Untreated 
hearing loss may lead to social isolation and may interfere with the wish of many 
elderly to live independently. Con-elations between hearing impairment, depression 
and cognitive impairment have been described. The regular use of a hearing aid can 
improve conmmn1cative and cognitive functioning and increase quality of life. 
Hearing impairment, however, is often not recognised, even not in patients who visit 
their physician regularly. 
A systematic assessment of hearing loss by audiometric screening will identify some 
patients who may benefit from the use of a hearing aid. Hmvever, it has been observed 
that the effect of a single screen with a pure tone audiometer, as measured by the 
provision of hearing aids, is not optimal. Repeated hearing assessments may help to 
remind patients and physicians of the continued need of assessing the possible 
benefits of hearing aids. Furthermore, repeated screenings will allow the detection of 
new cases and the identification of patients with progressive hearing loss. 
The aim of the study described in chapter 6 was to assess the value of repeated 
audiometric screens offered to elderly in general practice. In 1991, an audiometric 
screen was performed on 660 participants, simultaneously with the first 
cardiovascular health check. We repeated the audiometric screen 5 years later in 
80.2% (405/505) of the eligible participants of the first screen. After the first screen, 
28.2% of those who had an indication for a hearing aid, i.e. who had a hearing loss of 
40 dB or more in the right or left car, had discussed this with their general 
practitioner, 24.3% were referred to a specialist in otolaryngology and 16.9% had 
been prescribed a hearing aid. The effect of the repeated screen was lower as only 
9.9% of the hearing impaired pm1icipants received a hearing aid. 
We conclude that efforts to screen on hearing loss will be fmitless and can best be 
avoided in general practice unless strategies are developed to increase the use of 
hearing aids after a positive screening result. 
In chapter 7 the implications of the studies reported in this thesis are mentioned. Both 
the screening on cardiovascular risk indicators and on hearing loss offer the OP ample 
new information on the health of their older patients. Screening on hypertension or 
isolated systolic hypertension by a combination of case finding and screening by 
invitation and a regular review of the cardiovascular medication used by older adults 
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should be introduced in general practice. To assure systematic execution of these 
programmes and adequate follow up, improvement of practice organisation is 
mandatory. 
Until now, screening on hearing loss fails to live up to its promises. Although many 
patients with hearing loss could be identified, only a minority accepted an 
intervention, the issuing of a hearing aid. Research should firstly be focused on the 
identification of barriers to accept an hearing aid and thus offer ways to better educate 




Gedurende de laatste decennia is het percentage ollderen in de bevolking van 
\Vesterse Ianden toegenomen. Op dit moment leven mensen langer dan ooit tevaren. 
In Nederland was in 1994 de levensverwachting bij de geboorte 2,1 jaar (mannen) en 
1,1 jaar (vrouwen) hager dan in 1980. In de toekomst zal de levensverwachting verder 
stijgen; voorspeld wordt dat rnannen in 2015 2,5 jaar en vrouwen 1 jaar langeI' leven 
dan nu. Helaas is dit langere leven voor ieder niet even gunstig omdat een deel van dat 
extra leven in ziekte wordt doorgebracht. Van de 74,3 jaar die mannen gemiddeld 
Ieven word! maar 60, I jaar in goede gezondheid beleefd. 
Gezien de schijnbaar onvennijdbare ziektelast die deze demografische 
ontwikkel1ngen met zich meebrengen, worden pogingen am gezond oud te worden 
steeds belangrijker. Preventieve maatregelen op ondere leeftijd bestaan uit het 
aanbieden van interventies die de kans op vroegtijdig overl1jden verkleinen, ziekten 
voorkomen of uitstellen en functionele beperkingen zo veel mogeJijk opheffen. Zo is 
bijvoorbecld het voorschrijven van middelen tegen hoge bloeddmk gericht ap uitstel 
van ziekte of sterfte terwijI het voorschrijven van een gehoorapparaat meer tat doel 
heeft het functionercn te optimaliseren. In het algemeen geldt dat hoe auder de 
persoon is, hoe meer het doel van preventie zich verplaatst naar het vaorkomen van 
functionele beperkingen. 
Preventie wordt tot het takenpakket van de huisarts gerekend, maar het gevcn van 
prevcntieve zorg aan auderen staat ter discussie. 
In hoofdstuk 1 worden de voor- en nadelen van preventieve zorg voor oudercn door 
de huisarls besproken. \Ve beperken ons in deze bespreking tot preventie van harl- en 
vaatziekten, de belangrijkste oorzaak van sterfte en ziekte. en tot de preventie van de 




Screening op cardiovasculaire risico-indicatoren en gehoorsverlies door huisartsen 
lijkt veelbelovend omdat het voidoet aan een groot aantal criteria van Wilson, die 
bepalen of screening wenselijk is. Twijfel blijft echtcr bestaan of prcventieve 
programma's weI op een continue basis kunncn worden uitgevoerd, of de faciliteitcn 
nodig voor verdere diagnostiek en behandeling in de huisartpraktijk beschikbaar zijn 
en of de verhouding tussell de kosten van het preventieve programma en de overige 
kosten van de gezondheidszorg zich weI goed verhouden. 
In aanvulling op deze criteria blijven er ook vragen bestaan over de toepasbaarheid 
van het bewijs over de doelmatigheid van interventies op oudere patienten die de 
huisarts bezoeken en de uitvoerbaarheid van preventieve programma's in de 
alledaagse praktijk 
In hoofdstuk 2 onderzochten we de uitvoerbaarheid en de diagnostisch en 
therapentische gevolgen van een screenings-onderzoek gericht op hart- en vaatziekten 
bij patienten van 60 jaar en ouder. 
In 1991 werden aIle personen boven de 60 jaar die in gocde gezondheid waren en 
ingeschreven als patient in de onderzoekspraktijk uitgenodigd voor het screenings-
ondcrzoek. Bij 805 patienten, 80% van degene die waren uitgenodigd, werd een 
cardiovasculair risicoprofiel bepaald door een onderzoeksarts. De ratio tussen het 
aantal nienw ontdekte risico-indicatoren en het aantal deelnemers was de belangrijkste 
uitkomstmaat. 
Bij 25.1 % van de deelnemers werden ecn of meer cardiovasculaire risico-indicatoren 
gevonden die niet eerder bekend waren bij de huisarts. Dit hetfof 38 (4.7%) patienten 
met hypertensie, 82 (10%) patienten met gelsolccrde systolische hypertensie, II 
(1.4%) patienten met diabetes mellitus en 63 (7.8%) patienten met 
hypercholesterolemie. Op basis van dit screenings-onderzoek werd bij aile patienten 
met nieuw ontdekte diabetes mellitus een behandeling gestart. Echter, na het 
ontdekken van hypertensie of een verhoogd cholesterol volgde meestal geen 
behandeling. 
Vit dit onderzoek blijkt dat, hoewel een eenmalig cardiovasculair screenings-
onderzoek veel nieuwe informatie oplevert, het uiteindelijke effect op de therapie 
gering is. Er moet meer aandacht komen voor het vertalen van de gunstige resuitaten 
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van Ihcrapie in klinisch onderzoek naar het voorschrijven van deze intcrventies in de 
huisartspraktijk. 
Omdat het fisico dat cen persoon loopt op het krijgcn van cen hart- en vaatziekten niet 
constant blijft kan het waardevol zijn cen screenings-onderzoek te herhalen. 
In hoofdstuk 3 beschrijven we de resultaten van het herhalen van het screenings-
onderzoek vijf jaar na het eerste onderzoek. AIle patienten die deel hadden genomen 
aan het eerste onderzoek, ingeschreven waren in de huisartspraktijk en in goede 
gezondheid waren werden hiervoor in 1996 uitgenodigd. Tachtig procent (n=509) van 
de patienten ging op deze uitnodiging in en nam deel aan het herhalingsonderzoek. 
Bij 14.5% van de deelnemers vond cen onderzoeksarts voor de huisarts nieuwe 
informatie, wat hestond uit patH::nten met hypertensie (2.2%), gei'soleerde systolische 
hypertensie (9.2%), diabetes mellitus (0.8%) en hypercholesterolaemie (3.5%). Een 
belangrijke bevinding was dat de aanwezigheid van 40% van deze risico indicatorcn 
al tijdens het eerste onderzoek was vastgesteld. 
Ollze conclusie Juidt dat herhaling van het cardiovasculaire screenings-onderzoek 
zeker zin heen, vooral voor het ontdekken van gei'soleerde systolische hypeliensie. De 
opbrengst van het herhalingsonderzoek zou even weI duidelijk mindel' zijn geweest 
indien er meer aandacht was besteed aan de resultaten van het eerste onderzoek. 
Verder is het efficicnter het herhalingsonderzoek uitsluitend te richten op het 
opsporen van gei'soieerde systolische hypertensie. Een algemene screening lijkt, zelfs 
voor een generalist ais de huisarts, te algemeen. 
Een screenings-onderzoek op het gebicd van hart- en vaatziekten door de huisarts kan 
zich verdeI' richten op het evalueren van de gebmikte cardiovasculaire medicatie en 
op het vcrkrijgen van clectrocardiografische gegevens om het cardiovasculaire fisico 
bctcr te kunnen inschatten. Onder de deelnemers van het herhaalde screenings-
onderzoek deden we twee aanvullcnde studies om de waarde van medicatie evaluatie 
en het electrocardiogram (EeG) vast te stell en. 
Het sub optimaal voorschrijven of het onjuist gebmik van cardiovasculaire medicatie 
kan, zeker bij ouderell, Jijden tot ongewenste effecten. Om deze effecten te 
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voorkomen wordt geadviseerd regelmatig het medicatiegebruik van ouderen te 
evalueren. In de Nederlandsc situatie echter, waar de medicatiebewaking goed 
ontwikkeld is, kan men zich afvragen of er voor dit advies wei een grond bestaat. In 
hoofdstuk 4 gaan we hierop in door de effecten van het evalueren van 
cardiovasculaire medicatie te kwantificeren. 
In het totaal werden 560 mannen en vrouwen van 64 jaar en ouder ge'interviewd over 
hun mcdicatiegebmik. ·AIle gebmikte mcdicatie, doseringen, voorschrijvers en 
redencn voor geb11lik werden geregistreerd. Na het intervicw werd de informatie van 
degenen die cardiovasculaire medicatie gebruikten (n::;209) vergeleken met de 
informatie over medicatiegebmik uit het electronisch mcdisch dossier van de huisarts. 
De huism1s was op de hoogte van 92% van de voorgeschreven cardiovasculaire 
mcdicatie die door hun oudere patienten werd gebmikt. Doseringcn lager dan de 
minimum effectieve dosis stonden op 19% van de recepten en bij 18% van de 
rccepten was eell interactie met een ander gebmikt geneesmiddel mogeJijk. V~~r de 
behandcling van hypertensie, angina pectoris en hm1falen werd weinig gebmik 
gemaakt van het middel van eerste keus volgens de NHG-standaardcn. Vaak waren 
patienten niet op de hoogte van de indicatie voor het gebruik van hun geneesmiddel. 
Mcdicatie evaluatie biedt veel mogelijkheden het cardiovasculaire medicatiegebmik 
te optimaliseren. Het is daarom eCll waardevol middel om veilig ell doeltreffend 
gebruik van cardiovasculaire medicatie door ouderen te garanderen, zelfs wanneer 
medicatie controle al op cen hoog niveau staat. 
Electrocardiografie wordt veel gebmikt in de klinischc praktijk voor de diagnostiek en 
behandeling van hm1ziekten. Hiernaast kan een huisarts overwegen het ECG te 
gebruiken om het cardiovasculairc risico bij asymptomatische patienten betcr in te 
schatten. 
In hoofdstuk 5 vermelden we de resultaten van een studie naar de waarde van 
electrocardiografische screening van ouderen in de huisartspraktijk. Bij 489 patienten 
van 64 jaar en ouder werd cen ECG gcmaakt. Het ECG werd vervolgens 
gei"nterpreteerd met behulp van de computer door het Modular ECG Analysis System 
(MEANS), een gevalideerd ECG intelpretatie programma. 
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In het totaal werd bij 41.7% van aile deelnemers cen ECG afwijking gevonden. De 
vDlgende, niet eerder bekende ECG afwijkingen werden aangetroffen bij 8.8% van de 
deelnemers; stille infarcten (4.9%), Iinkerventrikelhypertrofie (2.9%) en atrium 
fibrilleren (1.2%). Diabetes mellitus en hypertensie voorspelden, Dnafllankelijk van 
andere factoren, de de aanwezigheid van deze ECG afwijkingen. De mcest frequentc 
ovedgc ECG afwijkingen waren atdoventriculair blok (12.5%), deviatie van de 
frontale T as (10.7%) en een verlengd QTc interval (10.2%). 
Samenvattend kunnen we zcggen dat een op de tien gemaakte ECG's de huisnrts 
nicuwc informatie geeft over stille infarcten, linkerventrikelhypertrofie en atrium 
fibrilleren. \Vanneer de screening bcperkt zou worden tot pati1::nten met hYPc11ensie of 
diabetes mellitus zou de kosten effectiviteit van de EeG screening bij ouderen verder 
verbcteren. 
In hoofdstuk 6 vcrandert het onderwerp van hart- en vaatziekten, de meest 
levensbedreigende ziekte, naar een functioneel belangrijke beperking. 
slechthorendheid. 
Slechthorendheid is cen van de meest voorkomende beperkingen op oudere leeftijd. 
De gevolgen van slechthorendheid zijn sociale isolatie en een vermindering van het 
vermogen zelfstandig te leven. Ook zijn correlaties beschreven tussen 
slechthorendheid enerzijds en depressie en cognitieve stoomissen anderzijds. Het 
gebruik van een gehoorapparaat verbetert het communicatieve en cognitieve 
functioneren en verbetert de kwal1teit van leven. Vaak wordt slechthorendheid niet 
herkend, ook al bezoeken patienten hun huisarts regelmatig. 
Een systematisch onderzoek naar gehoorsverlies door audiometrische screening zal 
patienten ontdekken die kunnen profiteren van een gehoorapparaat. Uit dit soort 
onderzoeken is echter gebJeken dat het aantal gehoorapparaten dat na de screening 
wordt voorgeschreven minder is dan verwacht. Herhaling van het gehooronderzoek 
biedt dan mogeJijkheid aan patienten en artsen de mogelijkheden van een 
gehoorapparaat te heroverwegen. Bovendien kan herhaling nuttig zijn om nieuwe 
patienten met slechthorendheid te ontdekken en om de progressie van het 
gehoorsverlies vast te leggen. 
Het doel van het onderzoek dat in hoofdstuk 6 beschreven wordt is het vaststellen van 
de waarde van een herhaald audiometrisch onderzoek naar slechthorendheid. In 1991 
122 
SAMEN\'A7TING 
werd. gelijktijdig met het scrcenend onderzoek naar hart- en vaatziekte. bij 660 
deelnemers een audiogram gemaakt. \Vij herhaalden het audiogram vijf jaar later in 
80.2% (405/505) van de patienten die nog uitgenodigd konden worden voor het 
onderzoek. Tijdens het eerste onderzoek werd bij 247 (37.4%) deelnemers en tijdens 
het tweede onderzoek bij 137 (33.8%) deelnemers slechthorendheid vastgesteld. Na 
het eerste onderzoek wenl door 24.3% van de slcchthorende patienten het 
gehoorsverlies besproken met de huisarts. In het totaal 21.5% van de slechthorende 
patienten bracht een bezoek aan de KNO arts of cen audiologisch centnHll en 
uiteindelijk kreeg 12.1 % cen gehoorapparaat voorgeschreven. Het effect van de 
herhaalde screening was lager dan van de eerste screening; uiteindelijk ontvingen 
maar 7.3% van de slechthorenden een gehoorapparaat. 
Huisartsen kunnen beter wachten met screcnen op gehoorsverlies tOld at strategieen 
zijn ontwikkeld die een bctcr gebruik van gehoorapparaten als interventie bij 
gehoorsverlies garanderen. 
In hoofdstuk 7 worden de implicaties van de onderzoeken van dit proefschrift 
besproken. Enkele belangrijke controversen op het gebied van preventieve zorg voor 
ouderen worden besproken. Screening op fisico indicatoren voor hart- en vaatziekten 
en op gehoorsverlies bevindt zich op dit moment in een niemandsland tussen beloften 
en onzekerheden. Totdat wij meer zekerheden krijgen. is het raadzaam preventieve 
zorg voorzichtig in te voeren, gebasecrd op kcnnis die al weI beschikbaar is. Dit 
betekent dat op dit moment aileen plaats is voor een systematische opsporing van 
geYsoleerde systolische hypertensie bij ouderen tot 80 jaar. Van aile andere 





'No mall is all island, we are all part o/tlte conh'nent' Ernest Hemingway 
De promovendus als eenzame, in toenemende mate wereldvreemde, noeste werker 
aan zijn levenswerk behoort tot de voltooid verleden tijd. De rneeste proefschriften 
bevatten dankwoorden waarin gesproken wordt over samenwerking, wederzijdse 
inspiratie en relativering. Graag sIuit ik mij hierbij aan. 
Dit proefschrift is het resultaat van de samenwerking van twee menscn aan het 
Institllllt HlIisartsgeneeskllnde Rotterdam, prof. dr. A Prins en prof. dr. A.W. Hoes. 
Beste Ad en Arno, ik ben dankbaar voor de mogelijkbeden die jllilie mij geboden om 
dit onderzoek uit te voeren en cryan te leren. Ad, ik kan Iliet anders dan jOll als de 
vader van het onderzoek zien, enthousiast VOOf het onderwerp, met adviezen en 
opmerkingen waarin soms cen haast vaderlijke bezorgdheid in doorklonk. Als 
praktiserend huisarts was je ook een generalist, die het belang van het onderzoek voor 
de praktijk niet uit het DOg 'verloor. Na vier jaar samengewerkt te hebben wiI ik de titel 
van je inaguratie rede als voIgt parapraseren; 'Promoveren bij een audere hoogleraar, 
niet te laat'. Arno, jij bent gedurende het hele onderzoek mijn belangrijkste ijkpunt 
gcweest. Ik heb veel geleerd van jouw kennis over de klinische epidemiologie, die je 
puntig en met humor kon overbrengen. Je Conlll1entaar op mijn artikelen spelde ik, 
gedeeltelijk door het handschrift en gedeeJtelijk door het vermoeden dat het weer 
zinnig was. Groot was ook mijn opluchting toen bleek dat je ondanks de verhuizing 
van Rotterdam naar Utrecht bij het onderzoek betrokken wilde blijven. 
Een belangrijk gedeelte van dit onderzoek speelde zich even weI niet in Rotterdam 
maar in Krimpen aan den IJsseJ af. In de huisa1ispraktijk van Blankers, Van DaJsen, 
Eerdrnans-Dubbelt en ten Hoeve waar mijn onderzoek plaatsvond had ik altijd het 
gevoel welkom te zijn. Behalve de interresse van de huisartsen, droeg de gastvrije 
houding van de assistentes hiertoe bij. Zeker toen de gedachte aan de promotie nag 
een abstractie was, heb ik veel gehad aall de ondersteuning van Carin, Roelie, \Yendy 
en Erna. Bijzondere dank komt Kees van Dalsen toe voor het leggen van de 
fundamenten van het onderzoek in 1991. 
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Veel werk voor dit onderzoek is verricht door de keuze studenten Richard de Rooij, 
Kees Jan Avezaath, Robbert Kerseboom en Ajmal Nlalik. Zander julHe inbreng was 
het werken aan het onderzoek ongctwijfeld saaier en kritieklozer gcwccst. Dank voor 
jullie inzct. Laraine Visser-Isles wil ik bedanken voor haar hulp bij het veranderen 
van mijn manuscriptcn in voor 'native speakers' begdjpclijke Engels. 
Goede herinneringen bewaar ik aan mijn col1ega's op het Institllut 
Hllisartsgeneeskunde. 'De gang' leverde voor mellig problecm cen oplossing. Het 
zoeken naar de oplossing was bovendien vaak leuker dan het vinden van de oplossing. 
Ben Cost, met \vie ik mijn kumer deelde, bedankt voor je vriendschap en je selectieve 
doofheid voor mijn muziek. Sita Bierma, mijn enige AIO collega, hielp mij vaak aan 
een positieve kijk. Oak aan de andere jonge onderzoekers, Marjoiein, Marc, Wouter, 
Khing en Claudia heb ik veel te danken. Bedankt voor julHe samenwerking. Spcciale 
vermelding verdient RODS Bernsen, ondermeer voor het Jedigen van acute statistische 
nood. 
In de afgelopen tijd heb ik veel aan vrienden gehad die belangstellend bleven vragen 
naar mijn onderzoek, ondanks vaak onbegrijpelijke antwoorden. Verder was het 
heerlijk om juist niet aan het onderzoek te denken. Er is leven naast de klinische 
epidemiologie. Zo werd OBze zoon Jan halverwege het onderzoek geboren en maakt 
sindsdien een ontwikkeling mee waarbij de mijne flauwtjes afsteekt. 
Mijn ouders wil ik bedanken voor het vertrouwen dat ze mij van jongs af aan 
schon ken. en natuurlijk voor het betalen van hct collegegeld. Dit proefschrift is oak 
een beetje van julHe. 
Tot slot, lieve Leonie, je hebt eerst dit hele dankwoord moetcn lezen om je naam te 
vinden, maar de staat vooraan in mijn rijtje. Ik weet niet goed hoe, maar ik bedank je 
voor dit alles. 
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